Skip to main content

2018 – Dr. Muriel Brackstone

I would like to thank Dr. Chris Schlacta, Dr. Vivian McAllister, James IV Association Canadian Secretary, and Dr. Ken Leslie, my Division of General Surgery chair/chief, for having nominated me for this travel award. I have felt an incredible honour in being able to represent this association and have benefitted tremendously from the experience and resultant contacts and collaborations. I selected centers to visit during my travels that would provide me with a broad view of how breast cancer is treated surgically (similarities and differences) across countries, as well as purposing to meet highly productive clinician researchers in the field of breast clinical trials in order to further collaborative research opportunities.

2016 – Sean C. Grondin

Sean C. Grondin, MD MPH FRCSC FACS
2016 James IV Traveling Fellow

sean grondin

It was with great excitement that I learned that I had been selected as the 2016 James IV Traveling Fellow. I want to thank the former Head of the Department of Surgery at the University of Calgary, Dr. John Kortbeek, for nominating me for this prestigious award. I would also like to thank Dr. Janice Pasieka, a James IV Traveler from Calgary in 2006, and Dr. Vivian McAlister, Canadian Honorary Secretary for the James IV Association of Surgeons, for their advice and mentorship in the planning of my trip.

I divided my travel into two tours, the first to Australia and China, and the second to the United Kingdom (England and Scotland). Throughout my travels, my hosts and their colleagues were very warm, welcoming, and generous with their time. I am very grateful for the hospitality shown to me during my visits.

Australia

Sydney

I began my visit in late October 2016 in Sydney, Australia after a 16-hour flight from Canada. I spent the first day in this beautiful city touring the iconic Sydney Opera House, the Harbor Bridge and Botanical Gardens. I thoroughly enjoyed walking the neighborhoods and meeting friendly city residents.

sydney opera house

The next day I began the medical portion of the trip by visiting Mr. Tristan Yan at the Royal Prince Alfred Hospital. Mr. Yan is a renowned cardiothoracic surgeon who has expertise in minimally invasive thoracic surgery (MITS). Mr. Yan provided an interesting tour of the Royal Prince Alfred Hospital facility. I also visited with several members of the cardiothoracic care team before meeting with Mr. Paul Bannon, a cardiac surgeon with a strong interest in surgical education. Mr. Bannon and I spent a relaxed lunch discussing the pros and cons of various international healthcare systems. Later, Mr. Bannon took me for a tour of their new, very impressive, simulation facility. A highlight of the day was meeting with Dr. James Crista, a cardiothoracic resident at the Royal Prince Alfred Hospital. Dr. Crista is an enthusiastic young resident who provided interesting insights into cardiothoracic residency training in Australia. The day was capped off with a very enjoyable evening with Mr. Yan, Dr. Crista, Mr. Holden, and Prof. Brian McCaughan where I listened to a lively discussion regarding the history of cardiothoracic surgery in Australia.

The following day, Mr. Yan and I visited Sydney Adventist Hospital, a private care facility originally opened in 1903 as a quarantine hospital for new immigrants to Australia. The efficiency of the surgical suites was remarkable with Mr. Yan completing five video-assisted thoracoscopic surgery (VATS) lobectomies in addition to several other thoracic cases in one day. Although the day was busy, Mr. Yan demonstrated his superb technical skill while maintaining a relaxed atmosphere in the operating room. During the lunch break, I had the opportunity to meet hospital administrators to discuss the business aspects of healthcare delivery in the private practice setting. The day finished with a delicious supper with the anesthesia team.

sydney dinner

On the final day, I visited world famous Bondi beach and completed the Bondi to Bronte ocean coast walk. The city and ocean views were fabulous and the people were very friendly. The day finished with a tour of the campus at the University of Sydney. I left Sydney in the evening taking a short flight to Melbourne.

Tips for future Travelers: I highly recommend a visit to Sydney. The city is truly one of the most beautiful that I have visited and the people are warm and welcoming. The public transportation system was easy to navigate and the restaurants were excellent. I recommend staying at a centrally located hotel such as Sheraton on the Park given its easy access to the airport train and short walking distance to the Sydney Harbor.

Melbourne

On November 3, I met Mr. Philip Antippa at the Royal Melbourne Hospital. Mr. Antippa is a Senior Lecturer in the Department of Surgery at the University of Melbourne with a special interest in medical informatics. He is also an active musician and viola player, and runs the highly acclaimed doctors’ orchestra in Melbourne, Corpus Medicorum.

After a brief tour of this facility, Mr. Antippa hosted me as I participated in multi-disciplinary rounds (MDR) at Peter MacCallum Cancer Centre. The MDR provided a wonderful opportunity to discuss interesting cases and debate treatment options for patients. I enjoyed the strong evidence–based discussions highlighted by opinions from experienced clinicians. After the MDR, I toured the modern cancer center facility. I was fortunate to meet several surgical colleagues during my tour. The many similarities between the Canadian and Australian healthcare systems were highlighted in the many discussions with various providers throughout the day.

The following morning, I attended an informative lecture on safety with members of the Department of Surgery followed by a visit to the physician offices and clinics. During this visit, I was able to view the lung cancer research database created by Mr. Antippa. This database was truly remarkable and is an enviable tool for analyzing patient demographics and treatment results. The afternoon was spent observing Mr. Antippa performing consultations and reviewing challenging thoracic surgery cases. Mr. Antippa is a skilled communicator and it was inspiring observing him at the bedside relate to patients and families. The day finished with a lovely Asian Fusion dinner with Mr. Antippa and Mr. Gavin Wright.

melbourne dinner

The next day, I watched Mr. Antippa perform a VATS lobectomy with smooth surgical skill. Later in the day, we toured the Melbourne cultural district followed by lovely supper at his house with family and friends. The local ice cream and Moscato wine for dessert were a real treat.

Tips for future Travelers: Melbourne is the coastal capital of the southeastern Australian state of Victoria. At the city’s center is the modern Federation Square development with several bars and restaurants situated on the Yarra River. The Southbank area is home to the impressive Arts Centre Melbourne and the National Gallery of Victoria. Hotels in Old (Downtown) Melbourne are very affordable and offer easy access to a number of great shops and restaurants that are open late into the night.

Brisbane

On November 6, I flew to Brisbane and was met at the airport by Prof. David Gotley and his son Ben. Prof. Gotley is an upper gastrointestinal surgeon who is a member of the James IV Association of Surgeons. Interestingly, he visited a thoracic surgeon, Dr. Richard Finley, in Vancouver Canada during his James IV Traveling fellowship in 1997. After settling into my apartment, I enjoyed a lovely supper hosted at Prof. Gotley home with his sons James and Ben, and wife Trish.

brisbane with son

The next morning, I toured the Princess Alexandra Hospital accompanying Prof. Gotley and his team on ward rounds. Later, I visited the Translational Research Institute. After a lunch with house staff, I was fortunate to watch Prof. Gotley perform two surgical procedures (Heller myotomy and Toupet fundoplication) at the Mater Private Hospital. His attention to detail during the procedure was remarkable. Later that night I toured the bustling Brisbane waterfront.

Most of the following day was spent observing a complex colon interposition. The team approach of the surgeons in performing this challenging case was exemplary. Following the case I was treated to a wonderful steak dinner with Prof. Gotley. The discussion on mentoring trainees as well as career development strategies was excellent as was the tutorial on how to choose a good Australian steak.

Tips for future Travelers: Brisbane is the capital of Queensland and is the third largest city in Australia (population approx. 2 million). I recommend the river walk downtown with excellent views and a vibrant food scene. I stayed at an inexpensive apartment complex close to the hospital which afforded me an opportunity to do laundry in preparation for the next portion of my trip.

China

On my first morning in Shanghai, I was picked up at my hotel by Drs. Timmy Yang and Alan Sihoe. We navigated the busy streets to the Shanghai Pulmonary Hospital where we were hosted by Prof. Jiang, Chief of Surgery. During the morning surgical rounds over 50 lung cancer cases were efficiently reviewed in preparation for surgery. The day was spent moving freely between the 15-dedicated thoracic surgery operating rooms observing major thoracic cases (e.g. uniport and substernal VATS resections, VATS segmentectomies, etc). The technical skill of the surgeons and work ethic of the entire operative team was impressive.

The following morning, I presented Surgical Rounds on the current state of thoracic surgery in Canada. My talk was followed by an inspiring presentation by Prof. Murakaya from Japan on thoracic surgery simulation with soft 3D models. The remainder of the morning was spent watching multiple operations (57 booked cases) performed by Dr. Jiang and his colleagues. Later in the day, I transferred to a hotel close to the Bund in preparation for the ATEP (Asian Thoracoscopic Surgery Education Program) conference. A faculty dinner that night was entertaining with lively discussion with Profs. Date, Khan, Kyoto, Sihoe, and others.

china meeting

The next day, I attended the ATEP meeting presenting talks such as “MITS training in North America” and “How to write a scientific paper”. I was also privileged to participate on several panel discussions including the role of stereotactic body radiation therapy and the future of lung cancer surgery. The conference was excellent and afforded a great opportunity for international collaboration and exchange of ideas. On November 13, I returned to Canada for a brief stay to see my family and prepare for the second leg of my travels.

Tips for future Travelers: Shanghai is a very large city (population approx. 15 million) so having great hosts like I did to assist in planning the trip and navigating the city is highly beneficial. I suggest a visit to the Bund for great downtown city views (especially at night). Also, I would recommend embracing the local culinary cuisine in order to maximize the cultural experience. Importantly, travel visas to China require a fair amount of paperwork and time to obtain, so I recommend applying a few months before your travel.

china

United Kingdom

London

I arrived in London and stayed at the historic Royal College of Physicians and Surgeons of England medical building. This complex is home to several significant paintings and surgical artifacts. In addition, the adjacent Hunterian Museum boasts an amazing collection of human and non-human anatomical and pathological specimens, models, instruments, and paintings. My first full day was spent touring London and visiting several well-known landmarks such as Big Ben and the Tower of London.

tower of london
Middlesbrough

On November 20, I took a train from London to Middlesbrough to visit Mr. Joel Dunning. Mr. Dunning is a young innovative thoracic surgeon at James Cook University Hospital who is leading the way in the development of new MITS techniques such as micro lobectomy. I was fortunate to observe Mr. Dunning excellent surgical skill when he performed two micro lobectomy procedures. Postoperatively, I enjoyed a detailed discussion on his ERAS (early recovery after surgery) protocols. The evening was capped off with a lovely dinner after which Mr. Dunning interviewed me for a video about my James IV Traveling Fellowship experiences. (https://www.ctsnet.org/article/experiences-thoracic-travelling-fellowship)

Tips for future Travelers: Staying at the Royal College in London is affordable and allows a centrally located “home base’ close to major tourist attractions. Travel in London using the tube is safe and easy to navigate. Railway travel in England is suggested as it is relatively inexpensive and a relaxed way to see the countryside. While in the United Kingdom, I highly recommend attending a professional football match – it is a fantastic experience.

football match middlesbrough
Edinburgh

After spending a day touring Edinburgh, I visited the Royal Infirmary where I met with Mr. Richard Skipworth, a consultant GI surgeon, and Prof. Steve Wigmore, a hepatobiliary/transplant surgeon. Both meetings were very informative as we exchanged thoughts on the challenges of providing excellent clinical care in different health care models. A visit with Prof. Rowan Parks provided a great opportunity to discuss the organization of medical education in Scotland.

In the afternoon, a visit to the Medical Research Council (MRC) Laboratory for Inflammatory Research was hosted by Dr. Kevin Dhaliwal. The facility infrastructure and research personnel were inspiring. In particular, the work known as PROTEUS was impressive. This home-grown technology allows the user to visualize cellular changes arising from diseases of the lungs in real time. This multiplexed optical molecular imaging unit demonstrated how collaborative multi-disciplinary teams can have great success. The day wrapped up with a delicious supper with Prof. Wigmore, Prof. Parks, Mr. Skipworth, and Dr. Dhaliwal.

The next morning, I met with several surgical trainees at the Royal Infirmary who presented their research projects. Informative discussions on their research methodology and future ideas for investigation were outlined. Later, I met with the warm and welcoming Regius Professor O. James Garden. We went for lunch at the impressive ESSQ (Edinburgh Surgical Services Qualification) offices where staff demonstrated the advances made in online distance learning and their international surgical education programs. In the afternoon, Prof. Garden toured me through the historic streets of Edinburgh and showed me several noteworthy landmarks. In the late afternoon, I visited the University of Edinburgh campus and then joined Prof. Garden and colleagues for supper at the New Club.

edinburgh dinner with O. James Garden at the New Club

On the last day of my visit, I met with renowned thoracic surgeon, Prof. William (Bill) Walker. Prof Walker has trained numerous accomplished thoracic surgeons around the world. Prof. Walker insights into the use of the posterior approach for VATS lobectomy were fascinating. I particularly enjoyed our conversations as we shared his wonderful memories of my mentor and mutual friend, Dr. F.G. Pearson.

Tips for future Travelers: Staying at a nice hotel in downtown Edinburgh is very affordable and allows easy access to restaurants and historic landmarks by foot. A visit to the Surgeons’ Hall Museum and the University of Edinburgh campus is highly recommended.

Conclusion

I wish to first thank the James IV Association of Surgeons for selecting me as the 2016 James IV Traveling Fellow. I am truly honored. I am also incredibly indebted to my local hosts in Australia, China, and the United Kingdom who gave so generously of their time and knowledge. Their hospitality was unforgettable and a special part of an outstanding experience.

This Traveling Fellowship was an incredible opportunity that allowed me to develop new professional relationships and friendships, broaden my understanding of other health care systems, and enhance my thoracic surgery knowledge base. I look forward to future collaborations and exchanges with several of the visited sites and am sure that many of the individuals that I met will remain influential to me personally and professionally.

2015 – Lorenzo Ferri

Imperial College and Royal Marsden Hospital, London:

The first leg of my trip started with a short jaunt across the Atlantic to London with my family in tow. My wife Alison, and two children Chiara (11) and Luca (8) were excited to join me for the first two weeks of the traveling fellowship. We landed in Heathrow on a cloudy Saturday morning to be welcomed by my uncle, David Iron, a computer engineer, working ironically for a Montreal based IT company but having set his  sights on  a restarting lunar  exploration (lunarmissionone.com).  We spent  the first two days in the UK at his and my aunt’s, author/blogger Alexandra  Campbell (themiddlesizedgarden.co.uk), house in Faversham, a beautiful town in Kent. We were fortunate to have timed our visit with a medieval town festival celebrating the 800th anniversary of the Magna Carta, a 1281 copy of which Faversham possesses in the town archives. Our children enjoyed attending “knight school” replete with archery and axe throwing, the latter a skill I wish I had honed at an early age that might have served me well on some of my meetings with hospital administrators.
We took the Sunday evening train to London to prepare for my visit to Imperial College the following day. Nisha Patel and Karen Kerr had prepared a busy and exciting schedule for me over three days. Monday morning I met with Professor George Hanna, the director of Upper GI Surgery at Saint James hospital. I was scheduled to meet him in his office immediately prior to a benign esophageal operation that he was to perform. Thankfully anesthesiologist across the Globe share a common core value of procrastination, as it afforded us over two hours of excellent discussion in Professor Hanna’s office on several aspects of the management of malignant upper GI disease prior to he being called back to the operating theatre. I was impressed with his program’s research initiative of bringing Mass Spectrometry to the bedside to aid in clinical decision making, and entirely novel paradigm using metabolomics to impact patient care. Indeed later in the day I had lunch with one of his research fellows, Mazar and Karen Kerr, to discuss the projects in more detail, in which employs investigating the efficiency of volatile organic compounds in exhaled breath to differentiate patients with esophago-­‐gastric cancer from non-­‐ malignant conditions. With professor Hanna we discussed several potential research collaborations including the management of oligo-­‐metastatic disease in gastric cancer as well as the outcomes of high lymph node burden esophageal cancer. Over the next two days I met a number of research associates, fellows, and residents exploring numerous aspects of the very impressive academic surgical juggernaut that is the Imperial College Department of Surgery. I saw various complementary aspects of simulated and virtual surgical wards and operating suites all designed to enhance training of the next generation of surgeons.   What I found particularly impressive was the close collaboration between the physical sciences (particularly engineering and chemistry) and surgery in several of the projects I witnessed, including prototypes of next generation robotics and the use of metabolomics (termed “metabonomics” at Imperial College) to aid in the diagnosis and treatment of  patients with malignancy. The department of surgery employs several mass spectrometers in translational research at the clinical interface unlike any I am   aware across the globe. Two projects currently underway struck me as particularly genius.  He first is an electro-­‐cautery knife coupled to Mass Spec to provide real-­‐time MS analysis of volatile organic compounds as the surgeon cuts through tissue, say a liver or breast containing a cancer. The team has identified a panel of VOCs in the resulting smoke that indicates malignant tissue, providing immediate feedback that the surgeon may be too close to the tumour margin. Another project close to my heart was one in which Both George Hanna, and another future host on my James IVth travels, Jesper Lagergern of the Karolinska Institute, were co-­‐ investigators. This study involved a novel non-­‐ invasive diagnostic test for gastro-­‐esophageal adenocarcinoma based on MS analysis of exhaled breath.  The following day I spent the morning at the Royal Marsden Hospital, with Shanu Rasheed, a colorectal surgeon with Imperial College affiliation, as my guide through the clinical workings of the famous cancer centre. I had a long discussion with David Cunningham, a world-­‐renowned Upper GI oncologist who has authored many of the practice-­‐changing studies on gastric and esophageal carcinoma (e.g. MAGIC trial). It was exhilarating to meet and discuss with someone with whom I share a common opinion regarding the treatment of gasto-­‐esophageal adenocarcinoma and upon whose work I based my own trials investigating novel neoadjuvant chemotherapy regimens for this disease.
My final day, I gave a talk to the department of surgery on the evolving approach to neo-­‐adjuvant therapy for esophageal carcinomas. After my presentation I spent time talking with the world renown Italian esophageal surgeon Giovanni Zaninotto, who has cross appointments at Imperial and the University of Venice.  He has since appointed me as associate editor of the journal Diseases of the Esophagus. My visit concluded with having tea with Sir Ara Darzai’s in his office in which we discussed the challenges of running an academic surgical program, he offered important advice that I’m certain to heed.

Trinity College, Dublin Ireland

With family in town, we next travelled from London to Limerick to spend the weekend on the west coast of Ireland (Dingle Peninsula) and drove to Dublin for Monday. My visit to Trinity College was organized by my host John Reynolds, a world-­‐renowned esophageal surgeon.  Professor Reynolds has built a remarkably comprehensive upper GI cancer program with not only an innovative clinical structure managing all aspect of this disease, but also strong clinical, translational, and fundamental research closely enmeshed within the hospital. The tradition of internationally recognized esophageal cancer management runs deep at Trinity College, indeed it was at this institution where Dr Watson and colleagues completed the first positive neo-­‐adjuvant trial in esophageal adenocarcinoma published in the NEJM in 1996, and heralded the era of this approach for esophageal cancer. I spent the first day with Dr Reynolds and his team and witnessed surgery for several benign and malignant upper GI diseases, including a Laparoscopic Heller myotomy by Dr Reynold’s colleague. In speaking to John about achalasia I was impressed by the number of patients in whom they are able to avoid an operation with an aggressive approach with pneumatic dilation. Learning of their success employing pneumatic dilation in most patients with Achalasia, it may me reflect on the current, and I think misplaced, zeal in endoscopic myotomies (POEMs). If the Trinity College success with pneumatic dilation was universal, I feel that POEMs would have a very limited appeal in the management of Achalasia.
I spent the following day with Dr Reynolds and his bench/translational research group including the scientific director, Dr Jacintha O’Sullivan. After giving a talk on my benchwork research titled “Post-­‐operative complication and cancer recurrence: Dissecting the role of neutrophils in the metastatic process”, I was fortunate to spend the rest of the morning listening to numerous presentations from graduate students in the gastric and esophageal research group. I was greatly impressed with the outstanding quality of the research, as well as the innovative translational approach that Drs Reynolds and O’Sullivan have adopted, particularly their use of human tissue. Indeed I have borrowed their tissue culture technique to obtain conditioned media from human peritoneum for a new research program I am starting on peritoneal metastasis. Following the morning research session, Drs Reynolds and O’Sullivan invited me to visit with them the remarkable Trinity College main campus in the centre of Dublin.
The following morning I was filled with a mild sense of trepidation, as I walking into the Saint James Hospital of Trinity, a personal Lion’s Den considering I was about to give a talk on the merits of neoadjuvant chemotherapy, without radiotherapy, for esophago-­‐gastric adenocarcinoma to the oncology group that started the entire paradigm of neoadjuvant chemo-­‐radiotherapy for this disease.  I was surprised, and relieved, to see that Irish demeanor is far more civil than what I have endured at other centers  with a divergent opinion after giving a similar talk (I think I saw the boiling cauldrons of tar and feathers outside the lecture hall at MD Anderson a couple of years ago…). Indeed, although my talk at Trinity College titled “Refining Neoadjuvant Therapies for Esophageal Adenocarcinoma: En bloc Resection, Radiotherapy, Both or Neither?” did not yield any immediate converts to chemotherapy alone as a neo-­‐ adjuvant treatment, it was well received and generated a lot of interesting discussion. Furthermore, I was encouraged to hear that Dr Reynolds has enough clinical equipoise in this topic to have written and started the neo-­‐ AEGIS trial, in which neo-­‐adjuvant chemotherapy  (MAGIC regimen) will be compared to chemo-­‐radiotherapy (CROSS regimen).  He has already enrolled over  50  patients  in  Ireland,  and  has  recruited  numerous  centres  across  the  UK  to help reach the planned 700 patients. Afterwards, we discussed the challenges of standardizing the surgical therapy in these large multi-­‐institutional trials, particularly the potential confounding influence that en-­‐bloc esophagectomies may pose. I am greatly indebted to Dr Reynolds for his remarkable hospitality and I look forward to inviting him to McGill as a Visiting Professor in the near future.

Karolinska Institute, Stockholm Sweden

 After a week in Ireland, my family and I travelled to Stockholm to visit the prestigious Karolinska Institute. I planned my trip to the Karolinska so as to visit both the clinical epidemiology research group in esophageal cancer run by the husband and wife team of Jesper and Pernilla Lagergren as well as the very active clinical program lead by Magnus Nilsson at the Huddinge Hospital. My first day was spent with Magnus Nilsson, at the Karolinska Institute affiliated Huddinge Hospital approximately 10 km south of the downtown core. Magnus runs an outstanding Upper GI surgical division that includes not only stomach and esophagus, but also a very strong hepato-­‐pancreatico-­‐biliary service.  I attended the daily morning rounds for the service, to which all attending surgeons and trainees are present. All patients are discussed in detail, as well as the upcoming cases for the day. I was impressed that the Huddinge hospital is able to maintain these rounds given everyone’s very busy schedules, but recognize the importance of all surgeons reviewing cases together so that silos do not develop. It is a way that the Karolinska affiliated hospital is able to maintain communication and standards, both operative and peri-­‐operative, amongst all surgeons.  As the division is currently embarking on a revision of their peri-­‐operative guidelines and pathways for a number of upper GI cancer cases, was asked to talk on the Montreal General Hospital experience with enhanced recovery for esophageal cancer, a topic on which we have published extensively. After rounds, I joined Magnus in the operating theatre for a laparoscopic subtotal gastrectomy.  His approach has evolved over the past couple of years, largely due to the influence of a fellow from Japan, and uses a “4-­‐ hand” approach popularized in Tokyo in which two surgeons can operate simultaneously. I found this quite interesting and I have since adopted this technique, to the delight of my trainees. In between cases, Dr Nilsson and I talked in his office – under the gaze of an Alfred Nobel bust – on all things esophageal.  He had just completed analyzing the data from a Scandinavian trial for which he is PI comparing neoadjuvant chemotherapy to chemo-­‐radiotherapy for esophageal carcinoma, a topic true to my heart.  I look forward to the published manuscript, as it will help move the field forward, in addition to the other trial on this topic currently underway run by one of my earlier James IVth hosts – John Reynolds. At the completion of the day of operating – I sat with Dr Nilsson and his team to go over several video’s of operative procedures – including their prone approach for minimally invasive esophagectomy, a technique I plan to try in Montreal.
The following day I visited the remarkable Upper GI Cancer research group based at the Karolinska Institute’s downtown campus. This group of clinical epidemiologists is directed by the esophageal surgeon Dr Lagergren and is, without a doubt, the strongest and most productive clinical research program on upper GI cancer in the World. Dr Lagergren and his wife, Dr. Pernilla Lagergren, form a complementary research team with over 30 research assistants, associates, and students. They have access to one of the most comprehensive and complete National cancer registries, and have used it to publish on the pathogenesis of esophageal cancer, and outcomes of treatment thereof, in the leading medical journals including NEJM and JAMA. The two Dr Lagergens are able to perform clinical research on a National scale I though only possible at the single institution level.  I was most impressed with a current study in which every single patient whom has survived esophageal cancer for more than 5 years in the entire country of Sweden is visited by a trained research nurse to complete a focused quality of life questionnaire, nutritional assessment, and objective determinant of caretaker burden. The scope of the studies they are able to undertake at a National level is truly breathtaking. I look forwaed to collaborating with the Lagergren’s in the future. After a pleasant weekend in Sweden, my family returned home to Montreal as I continued  on with the next stop of my James IV traveling fellowship to Scotland and Northern England.

University of Edinburgh, Scotland

I arrived on a Monday afternoon and had some free time to visit Edinburgh and work on my next talk. That evening I was picked up at my hotel by the extremely hospitable and gregarious James Garden – chief of surgery at the Royal Infirmary of the University of Edinburgh. We were joined by several other upper GI surgeons -­‐ including the director of esophageal surgery at the Royal Infirmary – Mr. Simon Patterson Brown. Dinner was held at the New Club – a remarkable supper club with an outstanding view of the Edinburgh Castle, a view I took advantage of whilst drinking a superb Highland Park scotch recommended by my host James Garden.   The following day I spent meeting several members of the Upper GI surgery team starting with Ward Rounds accompanying Richard “Skip” Skipworth. We took the opportunity to discuss perioperative management of esophagectomy patients and compare the enhanced recovery clinical care pathways that we each use. This was followed by visiting the operative theatre with Skip in which he was performing an open Ivor Lewis (or Lewis Tanner) esophagectomy.
The University of Edinburgh Esophageal Cancer program is one of the UKs largest -­‐ and this was evident by the remarkable skill with which Dr Skipworth performed   the procedure. Throughout the day, I met with several other members of the department of Surgery including Steve Wigmore, Ewan Harrison, and Robert O’Neill. I was struck by the dynamic and innovative nature of the research being performed  at the Royal Infirmary, clearly a very strong academic unit and a leader in the UK. Mr O’Neill and I discussed the possibility of continuing collaborative efforts into the proteomic and metabolomic features of esophageal cancer   progression.
I finished my visit at the Royal Infirmary with a talk on the Endoscopic Management of Early Esophageal Malignancy. This presentation on the ablative and endoscopic resectional techniques was well received by the oncologists and endoscopists in attendance – indeed I had referred to a recent manuscript from their group that mirrors our experience at McGill.

The day concluded with a dinner at the Odine Restaurant with Drs Garden, Harrison, and Rowan Parks – a colorectal surgeon and next years’ James IVth Traveller. This seafood dinner was amongst the best I have had in recent memory and clearly  altered my opinion of Scottish cuisine mired in images of lumpy haggis.  The following day I spent visiting the Edinburgh Castle where I spotted some attire in  the Great Hall built by James IVth I may find useful at my next meeting with the McGill University Health Centre Hospital Administrators (see photo below). I next walked down the hill to Holyroodhouse Palace – the Queen’s official home in Scotland. I fortunately timed my trip by chance with the official visit of the Queen and was able to witness the pomp and circumstance in full display as she hosted Edinburgh’s leading citizens to a garden party.
Surprisingly, I did not see Professor Garden in presence, but it is possible I did not recognize him in his party hat.  Joking aside, I must formally thank Dr Garden for his incredible hospitality during my stay in Edinburgh, he went beyond the call of duty and the Quaich – a traditional Scottish drinking vessel for scotch -­‐ I received from him sits prominently on my desk. I have since tried the Highland Park in it, however it probably is best suited as a decorative memento of my trip to the University of Edinburgh. I concluded my very productive Edinburgh trip by boarding a train to Newcastle upon Tyne in Northern England.
 

Newcastle-­‐upon-­‐Tyne, England

For esophageal surgeons in the UK, Mike Griffin’s program at the Royal Victoria Infirmary of the University of Newcastle is the mecca. Over the past 25 years, Professor Griffin has built a remarkable and comprehensive Esophageal Cancer program covering the entire region of Northern England – the area of the World with the highest incidence of esophageal adenocarcinoma. In my estimation, this is likely one of the strongest esophageal program anywhere, on par with what John Wong, Tom DeMeester, and Rudiger Seiwert had built a bit a decade or two earlier in Hong Kong, Los Angeles, and Munich respectively.  Mike runs all aspects of the esophageal cancer program, from stage 1 – 4 and from diagnosis to death -­‐ hopefully with a long interval in between! I was fortunate to have visiting at the same time Marc van Berge Henegouwen and Suzanne Gisbertz, two surgeons from the Amsterdam Medical Center – a leading European esophageal cancer hospital. The presence of these two experienced surgeons with whom I conversed significantly, greatly enhanced my visit. The day began in the operating theatre with one of Dr Griffin’s colleagues, Arul Immanuel, performing an en bloc Ivor Lewis esophagectomy. I learned a lot of small technical details from the operation, and was intrigued by the circular stapling anastomotic technique that he and Mike have adopted and I plan to try this at home. This was followed by several cases of interventional gastroscopy performed by Professor Griffin – this gave us the opportunity to discuss the varying management options of Barrett’s esophagus and high-­‐grade dysplasia whilst he performed two cases of endosopic mucosal resection. The afternoon was rounded out with a series of research presentation by Dr Griffin’s group as well as my own talk on enhanced recovery after esophagectomy.  I was struck by the impressive breadth of Professor Griffin’s clinical research and the direct clinical applicability of the results – he himself gave a talk on vascular supply of the gastric conduit that was extremely informative. Despite my personal experience of approximately 500 esophagectomies, I found out that there was much more to learn on vascular anatomy of the  stomach.
The  following  morning  we  had  several  other  research  presentations, including  a  profoundly  interesting  one  in  which  Professor  Griffin  discussed  the public outreach and education program that he has instituted to increase the public awareness of esophageal cancer in Northern England. He has recruited the help of a mascot – the “esopha-­‐Goose” -­‐ to get the word across to the general public that esophageal cancer is a real health issue.  This is accompanied by a comprehensive   public campaign including lectures, posters, and even beer glass coasters in pubs! This was truly inspiring, and I believe that we should adopt much of what he has started in North America. We completed our visit with the Upper GI Multidisciplinary Meeting which is run across several sites in Northern England by videoconference. This was a completely exhaustive (and exhausting!) 3 hour meeting going over every active patient with esophageal cancer that the team manages. This final meeting concluded the European portion of my James IVth travelling fellowship. I returned home for a few weeks to tend to my own patients with esophageal cancer prior to embarking on the second leg of the fellowship to California and China.

University of Southern California, Los Angeles, United States

I took the opportunity of the James IVth to visit an esophageal surgery centre built       by an icon in the field.   Although Tom DeMeester has been retired for several years,   the USC division of thoracic surgery has continued his legacy in excellence in esophageal disease under the leadership of Jeffrey Hagen. My first day at the USC – Keck School of medicine started with the research rounds in which the members of      the division and research fellows discuss the projects under investigations.   I met     three members of the team, Drs Jeffrey Hagen, Daniel Oh, and Tom’s son Steven DeMeester.  I gave a talk titled “– The Influence of en-­‐bloc resection on neoadjuvant therapies in esophageal adenocarcinoma “  which  prompted  an  extensive  discussion into the value of radiotherapy in these circumstances as well as the overreaching    impact on the CROSS trial, despite its recognized shortcomings for adenocarcinoma histology.   I then accompanied Jeff Hagen and Daniel Oh to the operating theatre   where they performed two robotic cases with the latest generation Xi machine.   The   first was a robotic lobectomy for a growing lesion in the right lower lobe. As my exposure to the robot is essentially non-­‐existent at my own institution due to financial constraints of a single payer system, I was intrigued by the application and cost-­‐effectiveness of this technology for a procedure I would have done by VATS back home.  I was greatly impressed with the ability Jeff Hagen was able to control  what  amounted  to  a  rather  significant  injury  to  the  pulmonary  artery  using  the robot as well as multiple clips passed by the excellent bedside assistance of Daniel Oh. For the second case, Daniel Oh performed a robotic enucleation of a 3 cm mid-­‐esophageal leiomyoma. The visual optics of the procedure was truly illuminating, and I was impressed by the diligence and patience of Dr. Oh as he carefully dissected the tumour off of the mucosa millimeter by millimeter with remarkable skill.

The second day I spent with Steven DeMeester which started in the endoscopy suite.  I attended  three  gastroscopies, one of which was for Barrett’s esophagus where I was overblown by the significant personnel support endoscopists enjoy at USC. Steven then took me to visit LA County hospital which is a short walk from the private USC-­‐Keck Medical Centre. After reviewing inpatient cases with the residents, we talked quite a bit about the differing access to medical care depending on insurance coverage status in California. Coming from a single payer system with comprehensive medical coverage, this was quite an eye-­‐opener for me.

This afforded us the opportunity to discuss differences in management approach for this disease. His father built an impressive center for the study of esophageal disease with close collaboration between general and esophageal surgeons. For a generation of academic surgeon, USC was the epicenter of esophagology. Although there has been a split between the two specialties since DeMeester senior’s retirement, one can still witness the greatness that USC has held in the esophageal world. I was impressed walking along the halls seeing picture of past fellows, many of whom have since built internationally recognized careers in esophageal disease, most pertinent of which is coincidently my host at my final stop of the James IVth Travelling Fellowship, Simon Law of the University of Hong Kong.

University of Hong Kong and Shenzhen Hospital, China

It was with great pleasure and anticipation that I returned to the University of Hong Kong. I trained here in 2004 under the tutelage of John Wong, and could think of no greater honour than return as a James IVth Travelling Fellow. This department of surgery is widely regarded as one of the “musts” on the James IVth tour, and I fondly remember attending a dinner in 2004 as a lowly clinical fellow in honour of a James IV traveller from Wisconsin. I arrived at my hotel after a long plane ride from Sothern California with just 45 minutes to freshen prior to being picked up in a car by my previous mentor John Wong. We travelled to the Hong Kong Country Club in Aberdeen where we met another figure instrumental to my training at HKU, Simon Law and his wife Sharon. The following day started with the weekly department of surgery research rounds. These rounds showcase the research being performed by trainees of all levels across all divisions of the department.  Three presentations  were given: one from plastic surgery highlighting the use of inguinal lymph node free graft transfers to the axilla to treat post-­‐surgical lymphedema; another from the colorectal surgery division exploring microRNA profiles from colon cancer patient tissue as a predictor of response to chemotherapy; and finally a randomized trial exploring the utility of gum chewing in the context of an enhanced recovery pathway for colorectal cancer. Each talk was well prepared and presented in a professional manner. The rounds were presided by Simon Law, and insightful and helpful questions and comments into the research methods or presentation style were posed by CM Lo, the current chairman of surgery, and John Wong.  These 90-­‐minute rounds were followed by visiting the Surgical Research Laboratories with Dr Nikki Lee where we discussed several translational research projects in which we could collaborate. I returned to the Queen Mary Hospital to spend the rest of the day in the endoscopy suite with Daniel Tong, one of the Esophageal and Gastric surgery division consultants.  Daniel  performed several interventional gastroscopy cases including two ablation procedures for dysplasia and one particularly complex case comprising a broncho-­‐ esophageal fistula several months following an esophagectomy. We commiserated together  our  shared  experiences  with  this  devastating  complication  and  discussed the ideal treatment options. I followed this experience giving a talk on my research titled “Post-­‐operative complications and cancer recurrence: What can surgeons do to improve outcomes”.   It was particularly moving for me to give this talk at the Queen Mary Hospital, because it was precisely in this building that John Wong challenged me to explore this concept almost 12 years ago.   With his push, I continued this line of research moving from a single institutional review from the esophagectomy experience at HKU, to population based studies, to a 10 year translational and fundamental research career exploring the deleterious oncologic consequences of post surgical complications. Because of this I owe much of my academic success to John Wong’s initial investment in me.
Later in the same evening I was picked up at the hotel by CM Lo, the current chair of surgery for a dinner at the Aberdeen Marina Club.  We had dinner with Alan Sihoe, the head of thoracic surgery at the University of Hong Kong and a Canadian to boot. I discussed with CM the challenges of maintaining an academic unit in the present day in which scholarly activity is not valued by most health care systems. Dr Sihoe had come to the University of Hong Kong from its heated rival Chinese University of Hong Kong only in 2008, well after I had trained at the Queen Mary Hospital. He had been Anthony Yim’s partner for several years, a true pioneer in minimally invasive lobectomy. Indeed I had spent a couple of days with Dr Yim during my time at the Queen Mary Hospital in 2004, which allowed me to start one of Canada’s first VATS lobectomy programs when I returned to Montreal. Alan and I compared notes regarding our approaches to minimally invasive resection of the lung.
The next day I attended an operation by Simon Law and Daniel Tong for a woman     with a mid esophageal squamous cell carcinoma.  The University of Hong Kong  surgical approach had changed significantly. Simon has adopted an entirely minimally invasive approach, yet maintaining the en-­‐bloc resection principles that I learned when I trained there under him and John Wong. Although my technique has  also evolved to a minimally invasive approach, I learned a great deal from watching Simon and Daniel, particularly their approach in the abdomen. Following the     operation Simon and his wife Sharon hosted Daniel Tong and myself to a dinner at      the venerable Hong Kong Jockey  Club.

During my fellowship at the Queen Mary Hospital I became friends with several of the  trainees,  Joe  Fan  was  amongst  the  ones  who  welcomed  me  the  most  with  his kind demeanor and unrelenting humour.  Joe was a third year resident when I left in   2004 and he has since become a colorectal surgeon and the main local administrator charged with helping CM Lo build an academic surgical unit at the University of Hong Kong-­‐Shenzhen Hospital just across the border.  The Shenzhen regional authority  built  a  massive  hospital  4  years  ago  and  approached  the  University  of Hong Kong to staff and run the medical program to ensure that the stringent quality standards equal those at the Queen Mary Hospital. Many university surgeons at the University of Hong Kong travel the 45-­‐60 minutes from Central HK to the Shenzhen hospital once or twice a week to operate and mentor the local surgeons.   With CM Lo’s guidance, Joe Fan has built the surgical services at the hospital from scratch to      fill  the  bricks  and  mortar  provided  by  the  Shenzhen  government.   The  enormity  of this  venture  cannot  be  underestimated,  both  literally  and  figuratively.   This hospital is absolutely massive and was built to help manage the health care of one of China’s largest cities, a sprawling metropolis bordering HK of over 10 million people and the world’s fastest growing city.  This city was a hamlet of only 50,000 people less than 30 years ago. Although at 2000 beds, The University of Hong Kong-­‐Shenzhen Hospital is considered a mid sized hospital in China, the enormous footprint and physical layout  of the facility is breathtaking. More of a convention center or airport than hospital,  Joe actually has a bicycle in his office to help him get around in a timely fashion. I was particularly impressed with the “presidential suite”, a 5000 square meter wing of the hospital built for senior Communist party members should they fall ill. The government provided just the structure, and Joe Fan was charged with filling this vacuous space with personnel and equipment so as to provide surgical care equal to the high standards of the Queen Mary Hospital in Hong Kong. After our tour of the hospital, in which I had more exercise walking around this massive complex that I had in the previous couple of years, Joe and I talked about the interesting but complicated intersecting private and public health care systems that exist in China over lunch at an upscale adjacent mall that would not look out of place in Phoenix, Arizona.
The Hong Kong visit concluded my travelling fellowship and I returned to Montreal and a desk piled high with papers, and more than a couple administrative headaches, that accumulated in my absence. I am greatly indebted to the James IVth Association of Surgeons for supporting what has been the highlight of my academic career and allowed me to meet and cement great friendships with the esophageal community across the globe. I am certain that this experience will lead to many future collaborative research and teaching endeavors, indeed I have already had more than one trainee from the centers I visited contact me concerning coming to McGill for sub-­‐specialty clinical and research training.

2014 – Geoff Porter

Geoff Porter, Canadian James IV Traveling Fellow

I feel incredibly privileged to have been a Canadian James IV Travelling Fellow. My Fellowship had dual themes, reflective of my current professional interests: (1) clinical surgical oncology, with a focus on advanced GI malignancies; and (2) population-based cancer control strategies. I conducted my travels over 2 legs: (1) New Zealand/Australia in November/December 2014; and (2) Europe in April 2015

AUCKLAND

The host for my visit to New Zealand was Dr. Jonathan Koea. Jonathan is a New Zealand-trained surgeon who did both Surgical Oncology and Hepatobiliary training at Memorial Sloan Kettering. Aside from his clinical practice, where he is clearly very well-regarded, has had a substantial impact on hepatobiliary surgery in his country. He has trained eleven Fellows in hepatobiliary surgery, all of whom are practicing surgeons in New Zealand. Among of all of his accomplishments, of which there are many, he is most proud of this impact.
Shortly after my arrival in Auckland, I had the opportunity to meet several individuals at the North Shore Cancer Program involved in a recently announced New Zealand initiative which aims to ensure patients go from initial concerning symptomatology to first cancer treatment in 62 days. This is a national program, but involves local implementation, and is an excellent example of the importance of context in cancer quality initiatives. I was very impressed with the engagement, enthusiasm, and investment, specifically by the cancer nurse coordinators/navigators. The North Shore Cancer Program has adopted a very wide view to include everything from concerning symptomatology through surveillance; I contrast this to Canada where cancer navigation typically begins after first visit to the cancer centre and ends following the completion of active treatment.
I gave Grand Rounds at the North Shore Hospital entitled “Cancer Control: The Canadian Experience”. This is perhaps the first time I have ever given Rounds to an audience where I knew absolutely no one. They were an extremely gracious, inquiring, and interested group, and I greatly enjoyed several interesting discussions afterwards.
I had a wonderful dinner with Jonathan Koea and Richard Harmon, Head of the Department of General Surgery at North Shore. The discussion was wide ranging including clinical approaches in cancer care in general and some of the similarities and differences between Canada, New Zealand and the United States, where all three of us had spent time in our postgraduate training. Jonathan and Richard spoke of a clear desire to serve patients, which I came to discover is pervasive within the New Zealand surgical community. Specifically, Jonathan struck me as a thoughtful, energetic, and very forward thinking individual who, at the end of the day, places the New Zealand cancer patient first in all that he does.

WELLINGTON

In Wellington, I spent a day at Cancer Care New Zealand, the country’s national cancer control agency. Cancer Care New Zealand is an organization of modest size with an active national program in palliative care, a full country-wide cancer registry, and the previously-mentioned initiative of a 62 day target from concerning symptomatology to first treatment for all cancer patients.
In the morning, I gave a presentation regarding the Canadian experience with synoptic pathology and surgical reporting to the Board of the New Zealand Cancer Registry.   New Zealand is very active with the Australian College of Anatomic Pathologists, as well as in their work with the International Collaboration of Cancer Reporting (ICCR). Dr. Brent Truelove, a pathologist and Chair of the Cancer Registry Board is committed to the implementation of synoptic pathology reporting in New Zealand.
In the afternoon I attended a very interesting workshop where a model examining the impact of antenatal hepatitis B transmission on subsequent development of chronic liver disease and hepatocellular carcinoma was presented.   Although the number of hepatocellular carcinoma cases prevented was modest in the model, the impact on chronic liver disease was quite substantial. During this workshop, it struck me how cancer control challenges in prevention, diagnosis, and treatment amongst First Nation Canadians are in many ways quite similar to that of the Maori people of New Zealand.

CHRISTCHURCH

I was delighted to spend two days visiting Christchurch Hospital/University of Otago at Christchurch.   I attended both the Upper GI/Hepatobiliary Cancer multidisciplinary meeting as well as the Colorectal Cancer multidisciplinary meeting. I was incredibly impressed with the level of engagement, infrastructure support, and efficiency of this clinical working conference. All specialties were represented, and the meeting was exceedingly well-organized with rapid access to all pertinent clinical information as well as efficient pathology and radiology review. It is clear that the Christchurch Hospital has prioritized this type of activity, and the level of engagement from outside sites by teleconference was outstanding. I believe that one of the major reasons it works so well is the rather flat hierarchal structure; this was a theme I noted throughout my visit to Christchurch that was not restricted to multidisciplinary conferences. Although several more “academically prominent” physicians were present, it appeared all felt free to voice opinions and clear management plans emerged.
I was similarly impressed in my conversations with other surgeons, specifically Ross Roberts, Frank Frazzle, Richard Tapper, Greg Robertson, Tim Eglinton and Chris Wakeman. The group hosted me for a very lively and enjoyable dinner, including delicious cow cheeks, and I was struck by the collegiality and respect that seemed to be pervasive throughout the Department of General Surgery. The overall relaxed New Zealand nature indeed reminded me of my current situation in Nova Scotia.
I also had the opportunity to spend some time with surgical trainees, both junior and senior level, as well as Fellows. I was struck that completion of a research project as a mandatory element of surgical training in New Zealand; the lack of a peer-reviewed publication precludes writing final exams. The organization of GI cancer surgery in New Zealand certainly differs from Canada in that all esophageal and gastric surgery is within the domain of the Department of General Surgery whereas the lung cancer surgery is performed predominantly by cardiothoracic surgeons.
I gave two presentations during my visit to Christchurch, one entitled “Cancer Synoptic Reporting in Canada” and the second entitled “Cancer Control: The Canadian Experience”.
The host for my time in Christchurch was Saxon Connor, a Hepatobiliary/Upper G.I. Surgeon. Although I had not met Saxon previously, it was immediately apparent that he is an extremely unique individual with an infectious passion and energy for what he does. How many surgeons would take the time, on a weekly basis, to bring a coffee to a pathologist and review the gross and microscopic findings of the last week’s cases? Although some might call this “old school”, I would submit that Sax simply views such direct relationships as being key to providing excellent care and leading through example.
There is a “just do it” attitude that is pervasive in Christchurch. The cancer society tissue bank is an illustration of such where, with determination, a large and valuable tissue bank has been established from extremely modest resources. Finally, the physical devastation of the two earthquakes in Christchurch which occurred just over three years ago is striking. On reflection, I realize I think about natural disasters predominantly from the perspective of underdeveloped nations; I was amazed by the level of devastation and its continued impact in this very developed nation. In my estimation, only 10% of the downtown core is currently usable; gravel parking lots representing demolished buildings are aplenty. In my meetings with the Chief of Surgery, Greg Robertson recounted with pride the acute disaster management and staff engagement in the time of change since. The building of the new hospital, eagerly awaited, has been a testament to the quiet but efficient determination of those who remain in Christchurch.

MELBOURNE

I had the great pleasure and privilege to be one of 200 invitees to the World Cancer Leader Summit in advance of the UICC World Cancer Congress in Melbourne, Australia. This one-day summit was structured around the theme of economics in cancer prevention and control. There are now more cancers deaths in low and middle income countries than in high income countries (previously, most cancers were in high income countries); the global cancer burden has never been greater. The day was illuminating, not just in the information and data presented, but in discussing the economic case to be made for cancer control interventions. Investments targeting tobacco control, diet and obesity related cancers, and vaccination will have profound positive cancer-specific health and economic effects. Simple structures and processes addressing early cancer detection, basic components of treatment (including surgery), and palliative care will undoubtedly be even more important moving forward.
I also had the opportunity to be faculty for a Master Course within the UICC World Cancer Congress. This course addressed the design of cancer system performance, and my talk covered knowledge translation/exchange activities and the specific benefits of cancer data presentation. I found the course participants were both engaged and remarkably well-informed; I learned a great deal and enjoyed the day thoroughly.
The UICC World Cancer Conference occurs every two years, last taking place in 2012 in Montreal.   I was struck by both the breadth and content of cancer control activities occurring around the world in high, middle and low income countries. Clear progress is being made, and Canada’s contribution is significant. More specifically, Dr. Mary Gospodarowicz, a radiation oncologist from Toronto is the President of the UICC, and Dr. Heather Bryant, Vice-President of the Canadian Partnership Against Cancer has made incredible contributions to UICC and international cancer control. The highlight of this meeting for me was a presentation by Canadian Stephen Lewis, where he used his extensive and successful experience with HIV in the developing world in considering the upcoming WHO non communicable disease (NCD) initiative to start in 2015 (where cancer will be an important element). His speech was a real “call to arms”; rather than presenting platitudes around progress to date, he made the strong case for an aggressive approach by the cancer control community at all fronts.
Following my time at the UICC Meeting, I had the opportunity to spend a day at the Peter MacCallum Cancer Centre in Melbourne, organized and hosted by Professor Sandy Heriot (a dynamic colorectal surgeon and Chief of Surgery at the Peter Mac). The Peter Mac is a remarkable institution; it is the largest free-standing cancer centre in Australia and is one of ten largest such cancer care facilities in the world. I received a wonderful tour of their impressive research facilities and met with several clinical faculty. During my Grand Rounds, I noted that the audience was exceedingly engaged and very interested in the similarities between cancer care in Australia and Canada. I had a very pleasant dinner with the Director of Research, Dr. Wayne Phillips as well as Michael Henderson, clearly a “father” of Surgical Oncology in Melbourne.
The following day I visited the Royal Melbourne Hospital, a large tertiary/quaternary care institution. I had a wonderful session in the morning with the General Surgery trainees and gave a clinical talk entitled “Liver Resection for Metastatic Colorectal Carcinoma”. This time with the house staff was coordinated by Robert Tasevski, who did his surgical oncology training in Toronto several years ago. He has a clinical practice in breast, endocrine and sarcoma surgery and is the equivalent of a Residency Program Director as per the Canadian model. I also met with Dr. Jim Bishop, Director of the Victoria Cancer Care Coalition. He is charged with the immense amalgamation of the “New Peter Mac” with surrounding health care institutions, including the Royal Melbourne Hospital. He is a seasoned administrator but clearly this > $1 billion new build, along with the important partnerships and collaborations that will ensue, is a massive undertaking. Finally, Professor Bruce Mann brought me to the Breast Multi-Disciplinary Rounds where I was once again impressed, as I was throughout my tour of Australia and New Zealand, with the functionality of this meeting. It does strike me that clinical leadership along with infrastructure support are critical success factors which seem to have been established throughout all the institutions I visited.
Bruce Mann (my host in Melbourne), provides a great example of the benefits of focused dedication.   The PROSPECT Trial, which he conceived and funded, aims to potentially reduce the need for radiation therapy based on pre-operative MRI criteria in patients undergoing breast conservation surgery. This trial is an example of how he has been able to bring focus not only from a research perspective but from a clinical perspective, to the Breast Program at the Royal Melbourne. Bruce is a highly accomplished surgeon and researcher, and a true gentleman. It was an absolute delight to spend an evening at his house with his children and wife Julie Miller (a very accomplished Endocrine Surgeon, they share an office!). The Mann/Miller family showed me great hospitality that I only hope one day I can repay.
I spent the following day with Bob Thomas, a surgeon who is now the Special Advisor on Cancer to the Department of Health in Victoria (equivalent to a provincial Ministry of Health in Canada). I gave a very well-attended talk entitled “Canadian Cancer Systems”. Bob Thomas explained some of the very impressive initiatives that are occurring within the state of Victoria specifically around its monitoring of hospital activities and trying to move through critical pathways of care for selected disease sites. As I noted in other areas of my visit of both Australia and New Zealand, the existence of dual public and private systems does present challenges specific to cancer. These challenges include, but are not limited to, data acquisition and monitoring as well as the embedding of standards within both systems.

ADELAIDE

 Upon arriving in Adelaide, Marcus Troschler, a young faculty upper GI/liver surgeon on staff at the Queen Elizabeth Hospital in Adelaide, picked me up from the airport. I was delighted to meet his four-year old son and have a beer with Marcus in the evening. Marcus underwent his residency training in Switzerland and came to Adelaide for fellowship training in upper GI and hepatobiliary surgery under the supervision of Professor Guy Maddern, and has stayed. Marcus strikes me as a young surgeon with abundant energy, intellect, and skill who will likely be important to the future direction of surgery in Adelaide. Despite a clear academic and clinical focus in HPB surgery, his staying in Adelaide required him to sit his Australian exams. This required him to go back to learning vasectomies and carpel tunnel repairs – skills which he continues to use as part of a week-long rotation in a “country hospital” approximately every eight weeks.
I spent a great day at the Royal Adelaide Hospital (RAH), the largest and oldest of Adelaide’s health care institutions where I had the opportunity to observe an upper GI multi-disciplinary tumor board. Again, this meeting was remarkably functional, chaired very capably by Dr. Sarah Harmer, another young faculty in Adelaide who had done her General Surgery training in Calgary, Alberta. I observed Ward Rounds where the entire team including faculty (junior and senior), surgical trainees and medical students round on a daily basis to review all patients. I gave rounds entitled “Overdiagnosis” to a group of GI physicians and surgeons and was again impressed by their great questions and engagement. Peter Debit, the Head of the Upper GI Surgery Program and Chris Worthley, Head of the HPB Unit at the RAH are clearly committed to patient care and are fiercely loyal to the history and clinical activities of the Royal Adelaide Hospital. A highly collegial citywide group of Upper GI and HPB surgeons met that evening for their monthly Journal Club. Over an absolutely wonderful meal I had the opportunity to talk about synoptic reporting in cancer surgery, as well as share many conversations and discussions regarding surgical education and clinical service delivery in Canada and Australia.
The following day was spent at the Queen Elizabeth Hospital and started with a morning “audit” of the clinical care delivered at one of the “country” hospitals in the small community of Whyalla, approximately an eight hour drive from Adelaide. The Adelaide residency program provides trainees, and faculty from the Queen Elizabeth hospital frequently rotate for a week at the institution (e.g. see above Marcus Troschler). The breadth of this audit, entirely put together by the Registrar who had just completed a three- month rotation, included, burns, colon resections, orthopedic cases, cesarean sections, and seemingly everything in between. I was struck with how well this tight affiliation between the QEH and “country hospitals” worked for both groups.
I spent several hours with the research trainees and was quite impressed with their “no nonsense” approach to lab research. I noted that the QEH Department of Surgery places on a significant priority on research training, but also requires research trainees to demonstrate independence and initiative in order to be successful. Lunch and far reaching discussions with the Honourable Andrew McLachlan (is a sitting elected member of the state Legislature in South Australia) as well as a retired surgeon Frank Bridgewater was a real privilege.
I visited ASERNIP-S (Australian safety and Efficacy Register of New investigational Procedures – Surgical), and was treated to several excellent presentations regarding the work of this group as it relates to technology approval, surgical training/simulation and breast cancer system performance. ASERNIP-S, a program of the Royal Australian College of Surgeons, was conceived and built by Professor Maddern, and is an excellent example of how outstanding focused work often brings many new and diverse opportunities.
I flew that evening to Port Lincoln with Jim Young; Jim was a longtime academic surgeon in Adelaide for many years, retiring officially from the Queen Elizabeth over five years ago. He periodically goes to “country” hospitals to provide General Surgery coverage for short periods of time, and was going to Port Lincoln to serve this purpose for the next week. Jim was an absolutely delightful gentleman with abundant experience, a love for the craft of surgery, and a highly entertaining personality – truly refreshing in a time where the day to day clinical and academic demands tend to wear one down. challenges. Upon my return from a Saturday of shark cage diving (an experience I will never forget), dinner with Jim where he talked about the sigmoid resection he had just performed with a family doctor and his training stories from the U.S. in the 1960s made for a memorable evening.
Professor Guy Maddern has had, and continues to have, a massive positive impact on surgery in Adelaide and South Australia. From ASERNIP-S, to surgical research training, to all aspects of clinical care delivery (including “country hospitals”), to the upcoming reorganization of surgical services in the city, to countless other initiatives/programs – Professor Maddern drives it all. He does do with both an energy and optimism that enables his success.

SYDNEY

I visited the Cancer Institute of New South Wales (CINSW) – the equivalent of a provincial cancer agency in Canada.   The CINSW has strong leadership comprised in its CEO, Dr. David Currow, as well as its Director, Sanchia Archivez. Both are highly impressive, and clearly focus on the importance of cancer control activities on improving cancer outcomes for the state. Although the CINSW does not have any direct clinical care mandate, it clearly is the “go to” organization for cancer related issues within the state of New South Wales. It has a strong approach to tobacco and sun tanning legislation, with a view towards activities that have tangible policy impacts.
The Cancer Information Analysis Unit of CINSW shares many of the approaches to cancer system performance measurement to Canada, as well as the challenges of data acquisition. Ainsling Kelly provided a fantastic overview of EviQ, a web-based informatics tool that has become the preferred resource for cancer professionals regarding clinical care. No analogous model exists in Canada, and I believe that there is opportunity for collaboration, perhaps through my role at the Canadian Partnership Against Cancer.
I also had the opportunity to visit the Royal Alexander Hospital, organized by Professor Michael Solomon. The remarkable infrastructure and surgery research engine at the Royal Alexander Hospital is largely attributable to Professor Solomon, who did colorectal fellowship training in Canada under Dr. Robin McLeod. He clearly has remarkable visionary and builder skills. I spent the morning at SOURCE, a surgical outcomes research unit established 10 years ago by Professor Solomon. SOURCE is a great example of clinician/clinical scientist collaboration with a strong focus in colorectal disease. The resultant establishment of an academic institute of surgery, which is essentially a hybrid model incorporating both hospital and university, has the potential to deal with the significant clinical strain of many Departments of Surgery. At SOURCE, I gave a presentation entitled “Cancer System Performance in Canada.” I had a great tour of RAH by Chery Koh, a relatively young faculty colorectal surgeon with a strong clinical and research interest in pelvic exenteration. The Royal Alexander Hospital is a world leader in pelvic exenteration; I don’t think there is anywhere else in the world which actually has a pelvic exenteration-specific multi-disciplinary tumor board!

AMSTERDAM

 I visited the V.U. Medical Centre (VUMC) in Amsterdam, hosted by the current Chairman of the Department of Surgery, Dr. Jaap Bonjer. Jaap was the previous Head of Surgery at Dalhousie University and, unfortunately for Canada, left for the VUMC approximately five years ago.
 The VUMC is an impressive facility. The hospital is run primarily by physicians, with surgeons being front and centre. Interestingly, the Department of Surgery also includes emergency medicine, stemming from a history where surgeons were the physicians that serviced the Emergency Room. The Department of Surgery is organized along divisional lines, most of which are similar to Canada but with some substantive differences. A trauma surgeon in the Netherlands does the full range of fracture care as well as basic neurosurgery and thoracic surgery. In fact, the vast majority of operative fracture care in the Netherlands is provided by such surgeons; orthopedic surgery is a completely separate training stream with a primary focus on arthroplasty.
 Clinical care within the VUMC is incredibly collaborative. On a daily basis all surgeons and trainees attend a 7:45 AM conference where all the nighttime operative cases and admissions are reviewed, and subsequent plans for inpatient care for the day are discussed. Approximately an hour later, a LEAN methodology-inspired approach to clinical care and patient disposition within their Rapid Admission Unit (<48 hour admission) occurs. Several years ago, not dissimilar the situation in many Canadian hospitals, the VUMC experienced long waits for patients who were admitted from the Emergency Rooms getting to an inpatient bed. They created a ward of 25 patients with an objective of a maximum 48 hour stay, after which either patients were discharged or were assigned to an actual hospital bed. To make this work, physician representatives across specialties meet every morning , where the actual plans are reviewed collaboratively. At 5:00 p.m., the Department of Surgery meets once again daily to review the upcoming cases for the evening, potential problem patients, and the planned operative cases for the following day.
 This whole process is quite interesting. Patients undergoing lumbar spine fixation for vertebral fractures are presented alongside cases of elective endovascular aortic aneurysm, non-operative aortic dissections, complex hepatobiliary surgery, and lung cancer resection. Although, as in Canada, VUMC surgeons have clearly defined areas of interest and expertise, it is recognized that all have potential input on patient care, particularly with the need for shared and efficient use of resources. In addition to the collaborative nature of rounds, the departmental members work together in other ways. It is not uncommon for a staff surgeon to be paged to help out in a clinic that was running late, even if it is not completely in their area of expertise. This is very different to how surgical care and surgeon autonomy has evolved in Canada.
I had the opportunity to witness several operative cases during my time at the VUMC. Theseincluded a laparoscopic mesorectal excision for rectal cancer using a three dimensional camera as well as an attempted minimally invasive thoracic esophageal cancer resection. I was struck by the clear commitment to innovation and technology advancement at the VUMC. Essentially no patients with esophageal carcinoma undergo open resection, and open resection for colorectal disease is confined to exceedingly complex and/or re-operative cases.
I also had the opportunity to spend time with Geert Kazemier, Professor of HPB Surgery and Director of the Cancer Centre at the VUMC. It is interesting that in the Netherlands, surgeons must enter their surgical cancer cases into a national registry; this is made mandatory by being linked to hospital reimbursement via the insurance companies. Although not truly population-based cancer registry (cancer patients not undergoing surgery are not included), it is a very interesting model that has worked well in the Netherlands. The cancer centre itself successfully leverages philanthropy for large equipment purchases, including a recent MRI/PET scanner, the first of its type in the Netherlands.
In my time with both the surgical residents and the surgical research trainees, I learned that in the Netherlands, trainees with an interest in a surgical career typically embark on research, usually in the form of a PhD, following a six-year medical school; this seems to be almost a requirement to subsequent admission for surgical training. Within Dr. Bonjer’s Department, there are eight such PhD students at present There are multiple examples at VUMC of such research trainees launching and completing large national or international randomized trials, including the recently published TIME trial of minimally invasive esophagectomy. Significant basic science and other health services research also occur in this setting.
I gave Grand Rounds during my time at the VUMC entitled “Cancer Control in Canada: The Example of System Performance”. I was struck by some of the similarities and important differences with the Netherlands pertinent to this topic. We had a very good discussion regarding the benefits and risks of public reporting of cancer outcomes.
Finally, I remain amazed by Jaap Bonjer. Although I knew him reasonably well from his time in Halifax, I remain amazed at his enthusiasm and determination in his administrative work. To his credit, he as clearly moved this department forward from an academic perspective while maintaining clinical excellence and significant innovation. Like several other surgical leaders I met through my travels, Jaap has his hand in just about everything from meeting on a bi-weekly basis with all research trainees (not just those he supervises), to a clear understanding of the clinical and academic work of all surgeons within his department, to the organization of diverse services within the hospital. He believes strongly in effective surgical management and is an outstanding communicator.

DUBLIN

The Royal College of Surgeons of Ireland (RCSI) is one of six medical schools in Ireland and is co-located with the Beaumont Hospital in Dublin, Ireland. I had the opportunity of presenting at their Grand Rounds with my presentation entitled “Overdiagnosis In Cancer: What the Surgeon Needs to Know”. Interestingly, as part of weekly Grand Rounds, verbal highlights of the current week’s New England Journal of Medicine were provided as was a brief presentation representing the journal article of the week and a brief interesting case presentation was also made. These hour long rounds, chaired very dynamically by Professor Arnold Hill (my host in Dublin) were dynamic, varied, and fast moving. The concept of integrating more than a single hour long presentation into an academic Grand Rounds was very engaging and effective.
I had the opportunity to witness research presentations by three separate trainees within the Department of Surgery. These included an examination of a large prospectively maintained breast imaging clinical database, as well as two other presentations representing several years of fundamental science experiments of endocrine resistant and aromatase inhibitor resistant breast cancer.   I was impressed not only with the quality of the presentations, but also with the clear thinking, focus and logical sequence of work they represented.   On my subsequent tour of the RCSI research areas, it was clear to me that programmatic focus in research is a true strength of the RCSI. Professor Hill’s vision, and a true strength of the research at the RCSI, is that research (particularly at a basic science level) cannot be all-encompassing; success will be best obtained with a more programmatic focused approach.
I greatly enjoyed an excellent dinner with Professor Hill as well as Professor Austin Leahy (a vascular surgeon) and Dr. Ann Hopkins (a primary scientist within the Department of Surgery).   We had a very wide ranging discussion including models of care and surgeon organization all the way through the trials and tribulations of child rearing in the setting of an active clinical practice.
Overall, there exists a clear commitment at RCSI to undergraduate medical education, specifically within the Department of Surgery. Professors Hill and Leahy, as well as Dr. Hopkins, spoke in great detail about the content of the undergraduate curriculum as well as the extensive reach of RCSI outside of Dublin (e.g. Malaysia and Bahrain). For example, the final oral examination for senior medical students, consisting of two major cases, was upcoming with the details clearly important to many of the faculty. I would be surprised if many academic Canadian surgeons knew the timing or content of medical school exams, and such exams would not be major events within typical Canadian Departments of Surgery. I left reflecting upon the mechanisms to reprioritize undergraduate medical education in what I do on a daily basis.
Finally, I was impressed with Professor Arnold Hill. Arnie is clearly a dynamic leader with an incredibly “large engine”. He has an active clinical practice in breast and endocrine surgery and has been the Professor & Head in the Department of Surgery at RCSI for almost ten years. Two years ago, he was appointed the Head of the School of Medicine at RCSI, the equivalent of a medical school Dean in Canada. He also maintains and supervises a very active lab research program. At a time where the aspiration of being a “triple threat” in surgery is often felt to be unrealistic, Professor Hill still clearly reaches and exceeds this bar.

LONDON

 I had the great privilege of visiting the Department of Biosurgery and Surgical Technology at St. Mary’s Hospital in London, part of the Imperial College of London (ICL), hosted by Professor Ara Darzi. Professor Darzi, a Lord and member of the Queen’s Privy Council, is an unbelievable visionary, surgeon and researcher. Dr. Karen Kerr, the Director of Research, facilitated my visit.
There are over 40 clinical research fellows at any one point in time across the five major research priority areas within the ICL Department of Surgery. I received a snapshot of some of this work, which included:

  • Use of virtual reality technology as a training technique
  • Simulation – a wide spectrum including surgical/procedure oriented, as well as situational (including OR camp). The simulation equipment at the Imperial College of London both within the Department of Biosurgery and Surgical Technology, and at the adjacent Patterson Building, certainly exceeds that of any other institution I have ever seen.
  • Metabonomics of suctioned air through a cautery/smoke evacuation system to guide cancer surgery
  • Anatomage anatomy lab – this looks remarkably like a shuffle board table, but provides remarkable anatomy demonstration in all planes.
  • A functioning neurogenomics laboratory which examines surgeon neuroactivity in real time as they are performing a variety of operative tasks
  • HELIX – an incredibly novel facility charged with creating new intelligent simple designs within health care.

The number of research projects, their organization, funding and productivity is truly incredible within the Imperial College of London. All research programs are multi-disciplinary and incorporate non-surgical personnel as required. Emphasis is placed on establishing proof of concept and clear progress. I had the opportunity to give rounds entitled “Canadian Cancer Control & System Performance” to a combination of academic consultant surgeons and clinical research fellows.
The following day, I had an extremely refreshing and insightful tour of The Royal Marsden Hospital by Shahnawaz Rasheed (Shanu). Shanu is a colorectal surgeon at the Marsden with a significant interest in rectal cancer and great experience in robotic approaches. Notwithstanding the impressive technology in the operating rooms (including the newest version of the DaVinci robot) of this very old facility ( > 150 years old!), I was most impressed with culture of the Marsden itself. Shanu appeared to know everybody who worked in the institution, and was on friendly terms with all from senior consultants to janitorial staff. Care of the cancer patient comes first and foremost at the Marsden, and its reputation as a top tiered cancer hospital seems is well-founded. “Just getting it done very well” seemed to be the mantra of the institution.
I then met with several individuals from the Centre For Health Policy, which has a clear affiliation with The World Innovation Summit For Health. Both are Chaired by Professor Darzi, and both have had significant impact. The World Innovation Summit of Health, a co-initiative of the Imperial College of London and the Qatar Foundation, has had two very successful Congresses, targeting high level health policy decision makers from around the world.   I was most interested by the work addressing value in cancer care, diffusion of healthcare innovation, and the delivery of universal health coverage. The model involves a very strong team of committed individuals who are able to leverage relationships with carefully selected Chairs for the individual content initiatives upon which they embark. The ICL’s Centre for Health Policy, and Department of Surgery, also have a big data unit directed by Ryan Callaghan. They have used UK discharge abstract data (HES) to examine complications and morbidity of surgery at a population level.
I met with the Chief of the Division of Surgery, Professor George Hanna, a noted upper GI surgeon, who also has significant expertise in quality assurance for surgical procedures. In addition to building a very strong Division, he also has an extremely active research program. Professor Hanna spoke eloquently about the different phenotypes that make up an academic surgery department, and made the case that almost all provide value. In my brief visit with him, Professor Hanna struck me as a very thoughtful and intelligent leader both from a clinical and research perspective.
I then had the opportunity to visit the Hunterian Museum, at the suggestion of Dr. Garth Warnock. For any surgeon who is visiting London, even as a tourist, 60 – 90 minutes at the Hunterian Museum is time well spent. Not only do you walk out of the museum gaining an appreciation of important surgical historical events, the layout of the museum was such that it made me consider the future of surgery. The depiction of vanguard practices “of the time”, both those subsequently well-accepted and those abandoned, makes one think about the eventual place of the vanguard procedures of today.
Overall, I expected that The James IV Fellowship would be a once in a lifetime professional opportunity; indeed it was. The benefits of observing other institutions’ approaches to clinical and academic surgery, combined with the exposure to a variety of cancer control systems, will have a lasting impact when I consider what I do, and how I do it.  I was left with a renewed enthusiasm for both the craft of surgery and the act of inquiry. Although there are marked differences in our environments, institutions and structures, it is clear to me that it is the people that are most responsible for an institution’s/organization’s success. At a time when we tend to focus in the things – operating room time, next generation laboratory molecular sequencing, the newest operating room technology – it is clear that smart, dynamic, passionate and visionary people are our greatest asset.

2013 – David R. Urbach

Imperial College London

I began my James IV travels in the United Kingdom at Imperial College London, Department of Biosurgery & Surgical Technology, in St Mary’s Hospital, Paddington. This Department, led by Professor the Lord Ara Darzi of Denham, is impressive: a large, exciting, innovative, and productive research unit, filled with some of the brightest, creative and most energetic researchers, clinical fellows, and young faculty that I have seen in all my travels in departments of surgery.
01
I began with an introduction to the Department, presented by Myutan Kulendran, a graduate student, and Karen Kerr. Karen functions as the director of research operations of the Department, supervising the direction, coordination and rigor of the academic activities, and working with members to develop and fund their projects. Professor Darzi’s vision is evident throughout this Department. Touring through the various research, education, simulation and clinical areas is probably best understood as exploring a physical rendering of the “homunculus” of Professor Darzi’s brain, a tangible realization of his vision of some of the most intriguing and exiting innovations in modern surgery.
Behind each door in the hallways of the Department of Biosurgery & Surgical Technology is something completely different, and you really have no idea what’s behind a door until you open it and walk inside. Is it a conventional research area with study carrels and graduate students? A laboratory with nuclear magnetic resonance and flow spectrometer analyzing cautery smoke effluent? A simulated operating room? Boardroom for policy discussions? A low-cost, deployable OR simulation environment for resource-poor settings?
02I began the first day of my visit with “Virtual Worlds and Medical Media”, an applied research program led by David Taylor (with Michael Taylor, a student) using computer based simulation for health and hospital-based applications. They work primarily using the program “Second Life”, creating hospital and ambulatory clinic environments that can be toured virtually, and tested for human factors and usability characteristics. They showed me an interesting example of their work in developing a chemotherapy satellite clinic for Memorial Sloan Kettering in New York, as well as creation of new hospital environments that attempt to better integrate primary care with hospital-based care, which historically has been treated quite differently in the National Health Service and way the Trusts are organized.
03Next, down the hall to another door, behind which was Laura Muirhead, a clinical research fellow, and a wet laboratory with heavy equipment including NMR and flow spectroscopy machines. In this lab, study “Metabonomics”, she focuses on the analysis of smoke effluent of surgical diathermy. Already, the lab has been able to make major progress in distinguishing factors such as tissue types. Ultimately, this type of analysis could distinguish whether or not a surgeon is cauterizing through a tissue margin involved with tumor, test whether a tissue sample consists of benign or malignant tissue, or provide information about the tissue type. The concept of point-of-care, real-time surgical diagnostics is a major theme of the department. The challenges remaining to be solved include modifying and miniaturizing equipment so it can be effectively used in an operating room environment, better characterization of tissue types based on cautery effluent analysis, and reducing the time required for these analyses to make the technique more useful at the point of care.
04Next, I moved to the Paterson Centre, a building that houses active clinical units (clinic, operating rooms, and surgical wards) with research space. The theme of integrating clinical care and research in the same physical space was another major theme of the Department. In the research floor, Zinah Sorefan and Matt Gold showed me the Distributed Simulation environment. Experience from theater make-up and prop skills are clearly an asset here. A low-cost, highly portable, and realistic looking OR simulation environment could be constructed and taken down in about 10 minutes. The distributed simulation focused on the key aspects required for simulation, focusing on features highly relevant to the content of the simulation (eg patient, monitors) and using low-cost props for features that are more peripheral to the exercise.
I next toured through a variety of simulation-based areas, including a Virtual Reality Laboratory (Pritam Singh), and OR Camp (Anisha Perera). These surgical simulation areas had all the retail off-the shelf simulators (VR trainers, MIST VR, Symbionix) as well as some simulators developed in-house.
05Phil Pucher, a clinical research fellow, led me through a tour of the Simulated Ward. This research space contains a physical simulation of a real hospital ward environment (in fact, the Distributed Simulation Environment had been constructed there just 10 minutes before, and disappeared by the time we returned to this room!). Innovation in all aspects of surgical care—pre- operative, operative, and post-operative—is another key theme of the Department of Biosurgery & Surgical Technology. Phil reviewed some results of some recent research he had conducted looking at the quality and outcomes of clinical surgical ward rounds. He evaluated the content of these rounds (information collected from history, physical examination, and charts) as well as assessment of non-technical skills of the surgical team.
Initially, the project Phil described seemed very familiar to me, but I didn’t realize the source of my dèja- vu. After a few minutes, though, I realized that I had been a discussant for that very paper that Phil had presented just two weeks before at a Surgical Forum Session at the American College of Surgeons meeting in Washington, DC!
Archie Hughes-Hallett and Philip Pratt demonstrated the Microbot Surgical Suite and Sensing Laboratory, including the “anatomage table”. Archie demonstrated the incredible advances made in three-dimensional imaging, image reconstruction, and image rendering and manipulation, all seeking to better integrate three-dimensional imaging into surgical procedures. Technologies allow the visual representation of deep tissue characteristics, helping to localize a tumor (for example, a renal cell carcinoma case that Archie, a urology registrar, demonstrated to me).
06I had lunch with Karen Kerr and members of the health policy team (Oliver Keown and Steve Beales) at the Frontline Restaurant just down the street. We had a fascinating conversation about new plans within the Department, including a new academic-industry partnership core to be built in a courtyard area at St. Mary’s hospital, to identify and incubate high-risk/high- reward projects that have the potential to impact health care around the world. I learned about the global summits of health care organized by the department, which focus on the key policy challenges facing health care decision makers and planners around the world.
In the afternoon, I returned to the 10th Floor Policy Boardroom of the Queen Elizabeth Queen Mother Building. Hutan Ashrafian presented to me some of the innovative work he has been doing in the area of bariatric surgery. In his talk “Beneficial Mechanisms of Bariatric Surgery”, he reviewed many of the current hypotheses of the metabolic, nutritional and other physiological aspects of bariatric surgery. Hutan’s work in understanding mechanisms of weight loss in bariatric surgery is masterful. I enjoyed on of his very descriptive slides outlining the evolution of bariatric procedures, including all the false-starts and dead ends over the years. The history of innovation in weight loss surgery undoubtedly has many lessons for future development in this area.
07At the end of the day, I presented my talk, entitled “What can be learned from non-randomised studies of surgical procedures?” Despite the lateness of the hour (17:00 on Monday), I was speaking to a full room of over 30 students, clinical fellows, and faculty. At the end of my presentation, I was asked several very insightful and thoughtful questions.
My second day at Imperial College began with meeting Elaine Burns and Anne Marie, one of her graduate students. Elaine is a colorectal surgery trainee focusing on Outcome Research in Surgery. She showed me some of her published and current research projects, looking at phenomena such as adverse event reporting and measuring quality, safety and avoidable mortality. We had a long discussion about some of the new and exciting areas in surgical outcomes research, including research on failure to rescue, how this is defined, and the implications for study.
08After lunch with Karen Kerr and Elaine Burns, I headed over to the Hamlyn Centre, in the South Kensington Campus of Imperial College. The Hamlyn Centre focuses on surgical robotic technologies. Professor Guang-Zhong Yang is the lead engineer who has led the majority of the projects from the technical and engineering side. I toured a showpiece museum of surgical robotics, including working surgical robots as well as informative and professional video presentations. Some of the new technologies being developed by the engineers are really exciting. In one room, I saw a demonstration of miniature three- dimensional portable accelerometers (worn over the ear) that can be used to quantify the quality and quantity of movement, for example in patients rehabilitating from orthopedic surgery. The potential for measurement of post-operative recovery in surgical patients is another exciting research opportunity. There are a number of 3-D printers that are used to provide rapid prototypes of newly designed and engineered devices, and machines to manufacture engineered products for robotics. Another new and exciting concept is a visual-field tracking mechanism that can guide surgical robots, essentially forcing the robotic arm to move a camera or instrument to move in the direction of an operator’s gaze, as measured by eye-movement tracking.
09I concluded my tour of Imperial College London with a visit to the Paterson Centre. Mr. Barry Paraskeva, Chief of Surgery, led me on a tour of the building. Once again, I was impressed by the physical proximity of research laboratories and creative spaces with real working clinical care environments. The clinical operations in the Paterson Centre are designed to maximize efficiency, ensuring close proximity of pre- operative, operative, and post-operative clinical areas, and smooth patient flow and transitions between units. I toured the theatres, where colorectal procedures and laparoscopic cholecystectomy were being performed.

University of Edinburgh

My host in Edinburgh was O James Garden, Regius Professor of Clinical Surgery and Honorary Consultant Surgeon. Professor Garden trained in Edinburgh, Glasgow and Paris from 1978 to 1988, as Chef de Clinique in the unit of Professor Henri Bismuth in hepatobiliary and liver transplant surgery. Professor Garden holds a number of international leadership positions in surgery, including President of IHPBA, Chairman of the British Journal of Surgery Society, Director of Surgical Distance Learning – Edinburgh Surgical Sciences Qualification (MSc Surgical Sciences, ChM in General Surgery), Member of Council of the Royal College of Surgeons of Edinburgh, Honorary Secretary of the James IV Association of Surgeons, and Editor-in-Chief of HPB.
We began my first day in Edinburgh with a fascinating tour of its surgical history, led by the premier guide to Scottish surgical tradition, Professor Garden. We surveyed the old Victorian-era construction of the Royal Infirmary of Edinburgh buildings, used as a functioning hospital until only a few years ago when the RIE moved to its new premises. This hospital was the center of complex surgery in Edinburgh, with operating rooms and Nightingale-style nursing wards functioning in a centuries-old structure. We visited the University of Edinburgh, with its buildings steeped in surgical tradition.
10Next we drove to the University of Edinburgh, past the old Anatomy Department where Professor Robert Knox worked as a renowned anatomy lecturer in the 19th century. Edinburgh’s rich surgical history is checkered by intriguing and peculiar characters, one of which was definitely Robert Knox. Knox’s career was ruined by the macabre “Burke and Hare” case. William Burke and William Hare discovered the value of corpses to Knox’s Anatomy Department, always in search of dissection material for teaching anatomy to the medical students. After accidentally discovering a dead body and selling it to Dr. Knox for a tidy profit, the two entrepreneurial conspirators solved the problem of their lack of cadavers for sale, by murdering the wretched poor living in the streets of Edinburgh. After murdering over a dozen people and selling their bodies to Knox, the two were caught. Hare was convinced to testify against Burke in court, who was hanged for the crimes.
Knox was never punished for his part in the business, which apparently angered the people off Edinburgh. Knox was harassed by the people and censured by the Royal College of Surgeons of Edinburgh, losing his prominent role in Edinburgh.
We did a quick tour of some of the University of Edinburgh buildings, including the neo-classical Playfair Library Hall, designed by William Henry Playfair, one of the great Scottish architects. William Henry Playfair was the nephew of the Scottish philosopher and mathematician John Playfair.
We next drove to the magnificent headquarters of the Royal College of Physicians of Edinburgh, now over 500 years old. Here were portraits of great surgeons, including Joseph Bell, who was a president of the Royal College of Surgeons of Edinburgh and personal physician to Queen Victoria when she visited Scotland. Bell was renowned for his excellent diagnostic skills, advocating close observation of patients to make a correct diagnosis. He would demonstrate his powers of observation to students by selecting a stranger, and guess his occupation or recent activities based solely on close observation. One of Bell’s clerks was Arthur Conan Doyle, the Scottish physician and creator of Sherlock Holmes. Conan Doyle credited Bell as the inspiration for the fictional detective Sherlock Holmes.
11Among the portraits in the College building was King James IV, considered a “renaissance” king, whose interest in science led to the incorporation of the Royal College of Surgeons of Edinburg in 1506. A portrait of Joseph Lister dominates the Fellows Room. Lister popularized the concept of antisepsis in surgery at the Glasgow Royal Infirmary. He used carbolic acid to sterilize surgical instruments and to disinfect wounds. At the Royal Infirmary of Edinburgh, Lister worked with the surgeon James Syme.
12Another notable portrait was John Bruce, founder of the James IV Association of Surgeons. In 1956 he was appointed Regius Professor of Surgery at Edinburgh University. He was editor of the Journal of the Royal College of Surgeons of Edinburgh. Bruce was knighted in 1963, and served as President of the Royal College of Surgeons of Edinburgh from 1957-1962.
After the tour of the Royal College of Surgeons of Edinburgh, Professor Garden drove me to the new Royal Infirmary of Edinburgh hospitals. Much more modern than the old premises, the building was partitioned between the University areas and the hospital. I first met with Professor 13Stephen Wigmore, Professor of Transplantation Surgery and Honorary Consultant Surgeon, and a previous James IV traveller. Professor Wigmore is head of Hepatobiliary-Pancreatic Surgical Services and Edinburgh Transplant Unit, Royal Infirmary of Edinburgh. His clinical interests lie in liver transplantation and hepatobiliary surgery. His principal research focus is on the cell and molecular biology of organ pre-conditioning and stress protein expression. Other research interests include the Kupffer cell, innate immunity, endotoxin handling and functional assessment of the liver in the context of surgery and transplantation. He is also involved in medical education and distance learning.
I spent some time with Dr David Pier and Dr Paula Smith, who introduced me to the Edinburgh surgical online distance learning programme. David Pier is Academic eFacilitator for the ChM in General Surgery and the ChM in Trauma and Orthopaedics, two online postgraduate programmes delivered in partnership between the University of Edinburgh and the Royal College of Surgeons of Edinburgh. His background is in the basic sciences; he has a BSc degree in Biochemistry from the University of Edinburgh and a PhD in Cancer Cell Biology from the University of Leicester. Paula Smith is Academic eFacilitator for the MSc in Surgical Sciences and the ChM in Urology.
David took me through a tour of the online educational programmes, including visits to the interactive discussion groups that make the educational program a much more active and participatory experience than typical self-study programs. The course is case-based, and highly interactive. The distance learning programmes started in 2007 with the launch of the MSc in Surgical Sciences. A ChM degree in General Surgery was added in 2011, followed by ChM degrees in Urology, Trauma and Orthopedics in 2012, and ChM degrees in Vascular and Endovascular Surgery in 2013. The MSc in Surgical Sciences is now the largest Master’s program offered at the University of Edinburgh, with approximately 115 new students per year. The ChM programs have also grown considerably, with nearly 400 students from 40 countries, raising revenues of approximately £1million per year.
The distance learning programs were developed in response to a number of needs that arose due to changes in surgical training, the most important of which was the significant restrictions in duty hours for postgraduate medical trainees in the United Kingdom. Limited hours of service provide limited opportunities for trainees to gain experience with all of the problems likely to be encountered in surgery. The distance learning programmes provide another mechanism to ensure that trainees have achieved a core knowledge base by the end of their training. Trainees are evaluated on standardized examinations, and also are assessed based on participation in the discussion groups. Active participation of many of the surgeons at the University of Edinburgh has been a key factor in the success of this program.
Hi met with Damian Mole, Clinician Scientist, Clinical Senior Lecturer and Honorary Consultant Surgeon at RIE. Over lunch, we discussed his research interest in inflammation and immune modulation, particularly in pancreatitis. Using in vitro and small animal models of experimental acute pancreatitis, Damian is focusing on better understanding the inflammatory pathways, and identifying therapeutic targets.
14My last meeting was with Andrew de Beaux. Andrew’s clinical practice focuses mainly on abdominal wall reconstruction, although he practised mainly foregut oncologic surgery earlier in his career. An amateur pilot, his office is covered with flight maps of Great Britain. We discussed surgical approaches for abdominal wall reconstruction, including component separation procedures, as well as composite tension free repairs with subfascial mesh. Andrew will be chairing the European Hernia Society’s 36th Annual International Congress in Edinburgh in May 2014.
The evening’s social event was dinner with Professors Garden and Wigmore and Damian Mole at Ondine Restaurant.

Western General Hospital

Specialty surgery is heavily regionalized in Scotland. The colorectal unit at the Western General Hospital is a unit of 13 surgeons, operating in up to 4 Operating Rooms on any given day. The colorectal division includes very successful researchers, such as Malcolm Dunlop, who had just learned he had been awarded a £5 million grant to continue his research on the genetics of colorectal cancer (while we were waiting for a cab to take me back to the airport).
In the morning I met Hugh Paterson, who accompanied me to the WGH multidisciplinary colorectal tumor board. I have attended many tumor boards, but I have never seen a tumor board like this one. First, it was fully attended by all the appropriate specialties: colorectal surgery, medical oncology, radiation oncology, pathology, diagnostic radiology, oncology nurses, and a tumor board coordinator. I counted 30 people in the room at one point. Second, we reviewed nearly 50 cases in 90 minutes—the radiologist was familiar with all the films (CT, MR, PET), and highlighted findings in a rapid-fire staccato. Third, they were highly organized. The tumor board coordinator had prepared summaries of all the cases with key information, and there was a printed guide to all the cases. Fourth, there was a videoconference link to other participating sites, and the telecommunications worked seamlessly.
The Division of General Surgery at WGH is really a colorectal surgery unit. The GPs and paramedics in Edinburgh and environs seem to really understand the division of surgical focus between the Royal Infirmary of Edinburgh and WGH; apparently all cases that seem like lower GI surgical problems are sent to WGH and all cases that seem like upper GI surgical problems go to RIE. Exactly how the GPs and paramedics can distinguish lower and upper GI surgical emergencies remains a mystery to me; our ER physicians and housestaff in fully equipped emergency departments sometimes get this wrong, and that’s with the benefit of CT scans. In any case, everything “from the duodenum down” goes to WGH, and everything else goes to RIE.
Because 90% of all care in Scotland is insured through the NHS, there appears to be little competition among surgeons for patients, and very little private surgery. That, in addition to its distributed geography and relatively small population of 5 million, has allowed Scotland to regionalize surgical services on an impressive scale, and without the turf warfare and acrimony you might expect.

Adelaide

15My host in Adelaide was Guy Maddern. He picked me up at the airport on my arrival, and he and Liliane graciously hosted me at their lovely home. I was provided with excellent accommodations in the guest room. The house was otherwise quite a bustling affair, housing Guy and Liliane’s children, a dog and three cats. I was hosted to a family dinner at the Maddern residence on my arrival.
This is quite an interesting time for surgery in Adelaide. The two major hospitals (Royal Adelaide and the Queen Elizabeth Hospital) are in the process of administrative merger, and Guy in instrumental in this administrative change. An enormous brand new hospital rising in Adelaide’s Central Business District is visible from the airplane as it approaches the Adelaide airport.
In the morning, Harsh Kanhere picked me up and drove me to the department of surgery at the Queen Elizabeth Hospital. I presented a talk entitled “What can be learned from non-randomised studies of surgical procedures?” I didn’t realize that Peter Hewett, lead author of one of the major articles I reviewed in my presentation (the “Australasian Randomized Clinical Study Comparing Laparoscopic and Conventional Open Surgical Treatments for Colon Cancer”) would be present. Luckily, it was favorably reviewed in my talk, avoiding any awkward explanations to my host audience. The talk was well received, and I fielded several thoughtful questions for the assembled audience.
16Following my lecture I joined a clinical governance meeting chaired by Guy. As I came to learn, Guy is integrally involved in almost all aspects of surgery in Adelaide. This particular meeting included a variety of people representing the Department of Surgery at the Queen Elizabeth hospital, including nurses and administrative leaders. A number of clinical issues were reviewed, including problems such as record-keeping by a physician whose handwriting was difficult to read, and where cataracts procedures should be done, particularly in light of the impending administrative changes in the Adelaide hospitals.
Mau Wee, a research resident, took me on a tour of the Basil Hetzel Institute (BHI) for Translational Health Research. Mau is originally from Malaysia, and is currently conducting research on liver reperfusion. Guy is his research supervisor. The BHI institute is a brand-new, state-of-the-art research building on the main campus area of the Queen Elizabeth Hospital. It has facilities for clinical trials and clinical research, as well as dry-lab carrel space, and wet labs. Over coffee, Mau explained his career pathway, including the residency training system in Australia.
I met with Guilherme Pena, a research fellow from Brazil who also works at the Royal Australasian College of Surgeons in simulation research (more about this below) and who will be joining the department as a clinical surgery resident next year, and Markus Trochsler, a young faculty member from Switzerland. They presented some of their research on the use of chitosan-dextran gel for use in adhesion prevention. Although I am familiar with some of the research on mechanical and chemical means of prevention of peritoneal adhesions, I had never heard of chitosan-dextran gel. It has been used in clinical applications by ENT surgeons for prevention of adhesions after nasal sinus surgery. Based on this success in human clinical use, Guilherme and Markus were tasked with conducting animal studies to explore its use in the peritoneal cavity.
They conducted a variety of experiments in rats and pigs. The pig experiments were most interesting, and it appears that the major problem at this point is the toxicity of chitosan-dextran gel in large animals. The first task was to create a pig model of severe adhesions, which they accomplished by a combination of peritonectomy and bowel suture. In initial studies, the pigs developed severe complications (bowel obstruction, perforation) due to the weight of crystallized material from the gel. To modify the delivery system, the concentration of the solution was changed. Currently, they seem to be noticing severe allergic reactions (desquamative skin eruptions) in the pigs after instillation of gel in the peritoneal cavity. The work continues.
I then met Guy at the Royal Australasian College of Surgeons building in Adelaide, where I spent the rest of the day. I toured the College buildings, including a beautiful old mansion which the College owns and uses for meetings and events, and another premises that the College rents for its working offices. The main headquarters of the Royal Australasian College of Surgeons is in Melbourne; I would visit that building 2 days later. The College has a number of Divisions. The Division of Research, Audit and Academic Practice, has a number of activities that Guy leads. These areas of concentration includes: Academic Surgery, ASERNIP-S, Morbidity Audits (such as the breast cancer audit), Mortality Audits, Project Office, and Scholarships).
One general theme of my James IV travels was a much better understanding of the structure of surgical organizations in the English-speaking world, particularly with respect to the role of universities, hospitals, and “Colleges” (which serve as one or more of: professional organization, self-regulatory organization, educational authority for residency training, assessment of competency, provider of licensure for surgical practice, provider and accreditor of continuing medical education for practicing surgeons, research funding organization, technology assessment authority, and consultant to government). The Royal Australasian College of Surgeons, which has authoritative jurisdiction over surgeons in Australia and New Zealand, is among the most active and influential Colleges that I encountered.
Guy leads a division of the College called ASERNIP-S (The Australian Safety & Efficacy Register of New Interventional Procedures – Surgical). This is a large technology assessment body, operated by a number of clinical epidemiologists who do the actual work of conducting systematic reviews, appraising evidence, and providing guidance. The agency that has authority for approval of new health products in Australia is the TGA. There is a body called MSAC, which advises governments about coverage of new health technologies (similar to the Ontario Health Technology Advisory Committee [OHTAC], where I was a member for several years).
The Division of Research, Audit and Academic Practice also conducts a number of other interesting activities. They are quite interested in non-technical skills in surgery, and I viewed a presentation fo simulation-based research looking at non-technical skills (communication, situation awareness) among surgical trainees using a tool called NOTTS. I also toured the simulation laboratory at the College building. They have two mobile simulation laboratories.
I then attended conference calls related to the Australian and New Zealand Audit of Surgical Mortality meeting. The audit is a really interesting initiative. The conference call was attended by regional heads of all the Australian states. The College requires mandatory reporting of all deaths in an Australian hospital when care was provided by a surgeon. Reports go through an initial screening and a secondary review by a peer reviewer. Peer review activity is compensated, and all information is protected by law. Participation in the audit is required for the College to provide CME attestation. There is incredible buy- in to the concept of the audit, and this is a hugely successful program. The audit does not just serve a quality assessment and quality improvement role, but also is a valuable source of research data, (one of the first articles related to the audit was just accepted in Annals of Surgery while I was in Adelaide).
I had dinner with surgeons of the upper GI unit (and spouses) in the Lion Hotel. My next day in Adelaide was not as full. Liliane took me on a driving tour of the city and to the beach for lunch. I then went back to the Queen Elizabeth Hospital, where I presented medical grand rounds entitled “Introduction of Surgical Safety Checklists in Ontario, Canada: Effectiveness in the real world”. Frank Bridgewater gave me a reprint of an article authored by him, Guy, and Glyn Jamieson, on problems with the Angelchik prosthesis. We had discussion at dinner about problems with the surgical literature, and how the literature has a lot of material on the benefits of new technology but not much about problems with technology. I hadn’t realized there was published literature on complications due to the Angelchik prosthesis.

Melbourne

My visit in Melbourne was coordinated by Robert Tasevski, an endocrine surgeon who was a graduate student with me in clinical epidemiology while he completed a surgical oncology fellowship at the University of Toronto. I spent my first night in Melbourne catching up with Rob, and exploring beautiful central Melbourne, one of the most beautiful and functional cities I have ever visited.
17I spent a morning in the clinical offices of Wendy Brown, President of the Obesity Surgical Society of Australia and New Zealand, and Director for the Centre for Obesity Research and Education (CORE) at the Glen Iris Private Surgical Hospital. The Glen Iris Private Surgical Hospital is a small private hospital in suburban Melbourne, which provides a variety of surgical services, including laparoscopic adjustable gastric bands. As a surgeon practicing bariatric surgery—principally laparoscopic Roux en Y gastric bypass—and with little experience with gastric bands, I was very interested in how patients are evaluated and followed up.
The morning was very informative and enlightening for me. Laparoscopic adjustable gastric bands are the mainstay of obesity surgery in Australia, which is a very different practice than our approach in Toronto, as well as in many other centres. I observed how closely and carefully the gastric band patients were followed, and 18came to appreciate the intensity of follow up that is required for a successful laparoscopic gastric band program. When I asked Wendy why so many bariatric procedures in Australia are gastric band placements, she explained that this was really a response to patient preference and demand. My observations in the clinic corroborated this; the Australian patients seemed very much against gastric bypass and other “permanent” and “invasive” procedures. There is a big social and cultural difference between Australian and North American patients who seek obesity surgery. Patients are followed incredibly closely, with multiple appointments and band adjustments. I learned that band adjustments are titrated to the patients’ perception of satiety/hunger, not dysphagia.
I met with Professor Jim Bishop AO, Executive Director of Victorian Comprehensive Cancer Centre (VCCC). There are major changes underway regarding cancer care in Melbourne, with development of a new multidisciplinary cancer centre. Prof. Bishop was very much interested in our experience with Cancer Care Ontario, in particular our experience with population-based cancer-related health services research. To this end, I was able to shed quite a bit of light on our activities, in my capacity as head of the cancer research program at the Institute for Clinical Evaluative Sciences (ICES), in Ontario Canada. Prof. Bishop was well-informed about the structure of Cancer Care Ontario, and had many several trips to Canada. He asked about our experience with quality reporting (particularly the Cancer System Quality Index, or CSQI) and our various publications, including an atlas of cancer surgery that I edited in 2008.
19I spent some time in the busy general surgery clinic of the Royal Melbourne Hospital with Julie Miller, a general surgeon who emigrated from the US who focuses on endocrine surgery. I saw several patients in the clinic with her and the trainees, and was impressed once again at how similar our patient problems are around the world, and particularly the difficult patient problems. We saw a patient with chronic abdominal pain who had undergone multiple previous laparotomies, with no obvious explanation for pain, but who was agitating for another laparotomy. I spent some time with the chief resident discussing some communication strategies for what we all thought would be a difficult patient encounter. I saw a patient with Julie who had a multinodular goiter with a dominant nodule, who presented to the clinic with no previous documentation or records. Julie had suggested a biopsy. The patient thought she already had one. This led to a (familiar to me) series of searches and calls to the family doctor to try to divine what tests and procedures the patient had already undergone.
I met with Bruce Mann, a previous James IV Travelling Fellow, and Head of Royal Melbourne Hospital & Royal Women’s Hospital Breast Service. Bruce was very helpful in coordinating my visit, and giving me helpful context on the practice of general surgery and hospital care in Melbourne. Bruce is also steeped in the knowledge of surgical history, and the James IV program in particular. Here I understood the value of a fellowship of surgeons who have been James IV travelers, who share a unique experience that only fellow travelers can relate to.
Bruce and I met with Dr Gareth Goodier, recently appointed Chief Executive of Melbourne Health. It quickly became evident to me that the main objective of the hospital was the implementation of an electronic patient record. I saw from my experience with Julie in the busy general surgery clinic that RMH had no electronic medical record system. The patient with chronic abdominal pain, for example, had a record consisting of several thick file folders comprising multiple hospitalizations, the earliest of which were archived and effectively inaccessible. I quickly understood that Gareth had been hired in large measure because he had recently introduced an EMR in Cambridge UK, where he had previously been a hospital executive. He asked many questions about our EPR at my hospital (Quadramed, as it turns out, although we were in the process of evaluating bids for a new EPR vendor).
I had a lovely dinner at the Flower Drum Restaurant in Melbourne, a very authentic Chinese restaurant. Bruce Mann and I were joined by other James IV fellows, including Julian Smith, and Donald “Scottie” Macleish. Scottie was a retired vascular surgeon, who is remarkably sharp and active for his years. He asked me about various colleagues of his in Toronto, none of whom I knew, expect for the ones who had lectures named after them. We shared wonderful food, conversation, and friendship. After dinner we walked to the Royal Australasian College Building, beautifully illuminated in the night, where Scottie gave me a lift back to my hotel.
I had an early morning the next day, leading a teaching session with the general surgery registrars on adrenal diseases, one of my clinical interests. The registrars were knowledgeable, attentive, and very appreciative for the opportunity of hosting a visitor. After my teaching session, I had breakfast with Rose Shakerian, General Surgeon and Research Fellow. Rose’s work focused on evaluation of a new acute care surgery service at RMH. I gave her my thoughts on how she could implement her study, which relied principally on detailed data from an existing database used to manage the acute care surgery service.
My last meeting in Melbourne before heading off to Sydney was with Prof. Danny Liew, Director of the Melbourne EpiCentre. This is a hospital-based epidemiologic research unit. The unit seemed to have all the right people—methodologists, statisticians, economists—and focused mostly on chronic disease research. What was missing was collaboration with clinical researchers, who could really benefit from the technical and methodologic expertise of the EpiCentre. This reinforced to me the importance of ensuring that research units are closely allied with the people who can best use their resources.
I wished Rob Tasevski farewell and expressed my sincere thanks, and headed off to Sydney.

Sydney

My visit to the Royal Prince Alfred Hospital and Professor Michael Solomon’s research unit (SOuRCe, Surgical Outcomes Research Centre) began in the morning when I met with Cherry Koh, a colorectal surgeon at the Royal Prince Alfred. Cherry took me on tour of the various hospital buildings, including the new cancer centre (The Chris O’Brien Cancer Institute). It was interesting to see this new cancer centre building, an entirely new construction, with new structures for oncology clinics and multidisciplinary teams. Cherry told me the story of Chris O’Brien, a popular Australian head and neck cancer surgeon who tragically died from glioblastoma multiforme in 2009. He had developed a proposal to transform the Sydney Cancer Centre into a modern comprehensive cancer centre, and raised funds from the Australian Government and philanthropic donors. The cancer centre will focus on patient centered care.
After seeing the new Melbourne and Syndey cancer centres, I realized how fractured cancer care is in many places around the world. The concept of comprehensive cancer centres, while popular in the United States and Canada, was a relatively new concept in Australia. The intent of the cancer centres is to integrate all the cancer care disciplines, to provide multidisciplinary and comprehensive care.
20Cherry also explained the history of the Royal Prince Alfred hospital. Prince Alfred, the son of Queen Victoria and Albert, was injured during an assassination attempt while visiting Sydney. He was treated at a hospital staffed by nurses trained by Florence Nightingale, and following his recovery, a public campaign to raise funds for a new hospital building was enacted by the people of Sydney to commemorate to survival of the prince.
I was very much interested in visiting the Surgical Outcomes Research Centre. I had first met Michael Solomon in the early 1990’s when he was a clinical fellow in colorectal surgery at Mount Sinai Hospital in Toronto, and where I was a clinical clerk in general surgery. Professor Solomon completed clinical epidemiology training with Robin McLeod, and had initiated a very productive and successful clinical research unit focused on clinical epidemiology.
I first met with Professor Jane Young, an epidemiologist focusing on cancer epidemiology who collaborates closely with Prof. Solomon. I then attended a SOuRCe Director’s meeting. Once again, it was interesting for me to see how leaders of clinical research units run their research operations. I learned about the funding of SOuRCe, and the challenges associated with ensuring continuing funding of a research unit. Prof. Solomon took me on a tour of the colorectral unit and research areas.
21I presented my talk—”What can be learned from non-randomsied studies of surgical procedures?”—to an interested group of researchers and clinical trainees. It was interesting to present this research to this particular group, since there was considerable overlap between the focus of my presentation and the work of SOuRCe. In fact, I cited several articles authored by Prof. Solomon, stemming both from his original work when he was in Toronto, as well as more recent work his group has done on the analysis of studies comparing laparoscopic and open colon surgery.
I had lunch with Cherry Koh at a Vietnamese restaurant in New Town, not far from the Royal Prince Alfred. She then took me on a tour of the beautiful campus of the University of Sydney, with its quadrangle and college buildings modeled after Cambridge.

Hong Kong

22My visit to Hong Kong was a highlight of my travels. I had never visited East Asia, and the opportunity to explore a different environment and culture was very exciting. I visited the Department of Surgery of the Li Ka Shing Faculty of Medicine, University of Hong Kong. My visit was based mainly at the Queen Mary Hospital in Hong Kong.
When I arrived, I met with Gloria Wong for introductions and formalities. Gloria was an administrative assistant to the Department of Surgery. By coincidence, Gloria had lived in Toronto some years ago, and we talked about the neighbourhoods where she had lived, and how the city had changed. I was presented with generous gifts upon my arrival, including a University of Hong Kong necktie, which I wore during my visit in addition to my James IV tie.
I then met with Professor James Wong, the well-known emeritus chair of the Department. We discussed some of the recent changes in the Department of Surgery at Queen Mary Hospital, as well as some of the opportunities that arose due to the opening up of China to partnerships with Hong Kong in health care. Prof. Wong asked me about acquaintances back in Toronto, including Dr. Bernard Langer, an accomplished academic surgeon and surgical leader in Toronto who was well-recognized around the world for his accomplishments in academic surgery.
23I met with Simon Law, an upper gastrointestinal surgeon, and had the opportunity to observe him in the operating room as he performed a laparoscopic gastrectomy. 24Watching the surgical technique of the surgeons at Queen Mary hospital was truly fascinating. I could see a clear difference in the approach to surgery from typical North American settings. The surgeons at Queen Mary were absolutely meticulous and precise, focused on clear anatomic planes, and operated in a field that was always bloodless. Surgeons would use a variety of hemostatic techniques—ultrasonic dissection, bipolar electrocautery, monopolar instruments—often in succession, and with the effect that I never observed a single drop of blood in the operative field. Vessels were always anticipated, identified, and precisely ligated. This made for operative procedures that were an absolute pleasure to observe.
After the specimen was resected, Prof. Law took the specimen to a back table, where he identified lymph nodes at various stations, dissected them out, labelled them, and sent them separately for pathologic evaluation. The care and attention paid to anatomic staging of lymph nodes was unprecedented in my experience.
I then met with Chung-Mau Lo, Chin Lan-Hong Professor and Chair of Hepatobiliary and Pancreatic Surgery, and Head, Department of Surgery at The University of Hong Kong. We had an interesting conversation about the issues in the Department of Surgery, as well as the new opportunities presented by the opening of China to collaboration in health care. The University of Hong Kong had just started a new collaboration with a new hospital in Shenzhen in mainland China. Surgeons from the University of Hong Kong were travelling to Shenzhen to perform surgical procedures and staff clinics.
25I had dinner with James IV fellows at the Shun Fung Restaurant, American Club, atop a skyscraper in central Hong Kong, overlooking the harbour and Kowloon. The main topic of discussion was the different health systems in different countries, their strengths and weaknesses, and how they influence the culture of medical practice. Interestingly, local news from Toronto—in this case, the ongoing saga of the wayward mayor of the City of Toronto, Rob Ford—had reached Hong Kong, and I was asked about our municipal politics as well!
The next morning I attended a clinical case conference attended by the entire Department of Surgery. The first case was presented by the plastic surgeons, a case of Ewing sarcoma involving the chest wall. The second case presented was that of a patient with an obstructing left sided colon cancer in the presence of cirrhosis and a hepatic mass. The patient, a prisoner, was present in the front of the conference room, available for26 examination. The imaging was reviewed, and I was asked for my clinical opinion. Not being a hepatic surgeon, I dug deep into my knowledge of the radiologic appearance of hepatocellular carcinoma, and based on the peripheral enhancement of the lesion on the contrast scan, I proposed that the hepatic mass was likely a hepatocellular carcinoma arising in the setting of cirrhosis, perhaps unrelated to the newly apparent obstructing colonic mass.
After the case conference, I was met by CC Foo, who took me to breakfast and tour of the hospital and research facilities.
We travelled to the nearby laboratory facilities of Department of Surgery at Li Ka Shing Faculty of Medicine, where Dr. K. Man presented her laboratory work.
I had lunch with Jensen Poon and CC Foo and a sushi restaurant not far from my hotel. After lunch, I had another opportunity to observe surgery at the Queen Mary hospital, this time a laparoscopic subtotal27colectomy, performed by Wai Lun Law, Anthony Cheung and Anne Cheung Professor in Innovative and Minimally Invasive Surgery, Chief of the Division of Colorectal Surgery, and director of the Surgical Skills Centre. The patient was a young man with attenuated polyposis and multiple colonic tumors. Once again, I was fascinated by the meticulous and completely hemostatic approach towards gastrointestinal surgery.
That evening, I presented my lecture “What Can Be Learned From Non-randomised Studies of Surgical Procedures?” Once again, the audience was very receptive, and asked many insightful questions. After my lecture, I was hosted to another wonderful dinner with a number of faculty and trainee surgeons. We were joined by Siu-Yin Chan, an upper GI surgeon who arrived late because she had been operating in Shenzhen all day.

Amsterdam VUMC

I had a wonderful time in Amsterdam, which included one of the worst hurricanes in recent years (which I somehow slept through due to jet lag), as well as visits to major art galleries, including the Rijksmuseum, Van Gogh museum and Anne Frank House. My itinerary at VUMC (Free University Medical Centre) included a number of academic events.
Professor Jaap Bonjer was my host in Amsterdam. He was recruited to Dalhousie University in Halifax, NS in 2004 from Erasmus University in Rotterdam, where he had a stellar career as an academic surgeon and trialist, coordinating landmark multicentre surgical trials such as the COLOR trial comparing laparoscopic vs open colon cancer surgery. He left Halifax in 2009 to take on the job of Head of the Department of Surgery and Chairman at VUMC, where he has nurtured an outstanding Department of Surgery.
I began my days with the surgical team’s clinical conference at 07:45. There were several surprising things about how the surgical department at VUMC functioned. First, the scope of the Department of Surgery is quite different from what we consider the scope of general surgery practice in North America. In the Netherlands, general surgeons call themselves “surgeons” rather than “general surgeons”. Their scope of clinical activities includes what we consider “general surgery” in North America (gastrointestinal surgery, surgical oncology, trauma, endocrine), but also includes much of emergency orthopedics (fracture management, including both closed reductions as well open reductions with internal fixations of extremity fractures, hip fractures, and spinal fractures except cervical spine fractures). The surgeons also perform vascular surgery (emergency and elective).
The second surprising aspect of how surgical care was organized was the comprehensive team approach. Rather than organization of surgical teams around specific staff or clinical programs, the entire team worked together as a truly integrated team. In the morning, the entire team (staff surgeons, residents, students) reviewed the cases admitted overnight, as well as the OR cases planned for the day. These rounds served simultaneously as a morbidity and mortality conference as well as a “business” meeting, during which the clinical activities of the day were planned and staffed. Although it was carried out in Dutch, I was able to follow the cases. Typical of Amsterdam, where so much transportation is by bicycle, one unfortunate case was reviewed of a young girl who was thrown from her bicycle during a collision with a bus. She sustained a contained disruption of her aortic arch, and presented to the ER stable with a wide mediastinum. Unfortunately, she became unstable during attempts to stent the aortic disruption, and emergency laparotomy and repair of the aortic tear was not successful in rescuing her.
I toured the Emergency Department at VUMC. The trauma system in Amsterdam differs from typical North American trauma teams, in that the transport trauma team includes a trauma surgeon, nurse and anesthetist who travel to the field for serious injuries. They could travel by helicopter or emergency response vehicle (not an ambulance equipped for transporting patients, but a vehicle able to navigate streets, with appropriate resuscitation equipment for field trauma interventions).
There were several postoperative care units that I toured in VUMC. One of these was an acute care unit; an inpatient unit intended for 48 hour stays. This unique hospital ward housed patients from a variety of services (surgery, internal medicine). Patients who could not be discharged within 48 hours were transferred to an appropriate destination unit within 48 hours. Most acute care surgical cases (appendicitis, cholecystitis) were discharged within the 48 hour period, making this unit a very sensible way to take pressure off the other hospital wards.
I joined the resident team for their clinical ward rounds. Residents in Europe are limited to a 48 hour work week, which in practice is quite a different work week than our residents are used to. For example, if a resident takes call on a Saturday, they are entitled to a lieu day off during the subsequent week. On call shifts for a day end at 10:00 P.M., with a new team replacing the resident who has taken call from 08:00 to 22:00. Rounds were attended by typical teams of surgical trainees and students.
I attended the ORs in VUMC. These were state of the art operating rooms, with full MIS functionality, as well as surgical robots (rarely used by the general surgeons). I spent much of one day observing a Whipple procedure.
I attended multidisciplinary endocrine oncology rounds. These rounds are typically attended by surgeons, endocrinologists, pathologists, and radiology. Several cases were presented, including a case of Cushing’s syndrome caused by multinodular adrenal hyperplasia (so called “AIMAH”, or ACTH- independent multinodular adrenal hyperplasia). I was asked how we manage these patients in Canada. The answer to the question was somewhat complex, since there is an active endocrine oncology unit in Montreal championed by Andre Lacroix, that investigates these patients aggressively, looking for endocrine responses to vasopressin, mixed meal, etc, and tailors treatment according to the specific endocrine receptor defect. In Toronto, we would typically resect one or both adrenal glands. Practice in Amsterdam was similar to our practice in Toronto. We reviewed the case of a bipolar patient on lithium with hypercalcemia and increased PTH who had twice been scheduled for parathyroidectomy (and who had then twice been cancelled due to a normal calcium level on the day before surgery). We decided to cancel her third booked surgery (scheduled for the next day!).
I spent some time with Professor Bonjer in his surgical outpatient clinic. It was somewhat reassuring to see that the vexing problems we face in academic surgical practice are quite similar in North America and Europe. In addition to the straightforward (inguinal hernia), we saw cases of chronic pain after ventral hernia repair (the Dutch appear to have solutions no better than our own; reassurance, setting expectations, encouraging non-pharmacological approaches [although Jaap seemed somewhat dubious of my suggestion of meditation, yoga or aerobic exercise], and non-narcotic pharmacologic approaches such as neuromodulator medications. We saw a complex patient who had been recovering in rehab from a stroke with a soft tissue lump in her lateral thigh. Not sure if this was lipodystrophy, fat necrosis, or a soft tissue neoplasm, we decided to send her for an MRI scan. Thankfully the patient with the inguinal hernia agreed to have surgery the next day, replacing a case for the bipolar patent on lithium whose parathyroid exploration had just been cancelled.
I meet with several PhD students at VUMC. Most of the students have clinical backgrounds, typically they have completed medical school and are either awaiting positions for academic residencies (residency training positions intended to achieve specialty training as a consultant) or medical school graduates hopeful of a surgical training position, but who are pursuing non-academic residencies (hospitalist or assistant physician positions) in the meantime. Most of these students’ projects were multicentered randomized controlled trials related to surgery. Students reviewed protocols for a study of selective decontamination of the digestive tract (SDD) prior to colorectal cancer surgery, as well as study of a laparoscopic vs open surgery for ventral hernia, and the COLOR-2 trial comparing laparoscopic and open surgery for rectal cancer.
I learned quite a bit about how the Europeans have been so successful at conducting surgical RCTs, at least in comparison with us North Americans (including the cooperative oncology study groups). The success of the Europeans has a lot to do with culture. Surgeons are enthusiastic participants in RCTs, enrolling patients, collecting data, and providing the data back to a central study coordinating centre without subject finding fees or other grants. Investigators are invited to annual or bi-annual investigators meetings. The central coordinating groups pay for their travel, housing and subsistence, and the meetings serve as key opportunities for academic linkage, exchange, and professional development of the participating surgeons. As a result, the large European surgical trials are run on a virtual shoestring. Typically the trials are overseen by one or two graduate students, with support of a statistician and database manager. Financial support may come from an industry grant, university grants, or academic funds from activities such as CME courses. The ability to enroll multiple sites and surgeons (for example, the COLOR 2 trial had 30 participating sites, none within the United States), has much to do with culture and engagement. It was an eye opener into what is possible when surgeons share a common interest in finding answers to the major questions that face us on a daily basis.
I gave a presentation to the VUMC Department of Surgery entitled “What can be learned from non- randomised studies of surgical procedures?” The lecture was well-received and participants asked many thoughtful questions. I must say it was somewhat awkward delivering a lecture that focused on all of the (insurmountable?) problems facing attempts to conduct RCTs of surgical procedures, in a department of surgery that is arguably the most successful coordinating centre of surgical RCTs in the world!

Israel

28In Israel, I visited the Hadassah Ein Kerem Medical Center in Jerusalem. There are two campuses of Hadassah Medical Center, on in Ein Kerem and one at the Hebrew University campus at Mount Scopus. Most of the activity in general surgery is at the Ein Kerem Campus. My host for the visit was Dr. Yoav Mintz, an MIS surgeon. I met with several surgeons, including Professor Aviram Nissan, head of the Department of Surgery at Hadassah. Professor Nissan is a surgical oncologist. I also met with Professor Avi Rivkind, Chair of the Department of Surgery, and an internationally recognized expert in trauma.
Dr. Mahmoud Abu Gazala, an associate surgeon in the department, met me in the morning and helped show me around the hospital. I gave a talk at the Department of Surgery morning rounds, entitled “Introduction of Surgical Safety Checklists in Canadian Hospitals”. I gave the talk in English, and I felt quite comfortable that it was understandable to all the attendees.
Following my lecture, I attended surgical academic rounds. One of the residents presented a case of29dysphagia occurring several years after a laparosco pic Nissen fundoplic ation. The case slides were presented in English—for my benefit—but the discussion was in Hebrew. I was able to follow 30With Professor Avi Rivkind, Chair of the Deaprtment of Surgery, Hebrew University much of the discussion, and when asked for my opinion I thought I was able to provide a reasonable approach to investigation and management.
After my lecture, Yoav led me on a tour of the hospital. He described several innovations in surgical practice, including a technique he has develope31d for laparoscopic sleeve gastrectomy in which he removes the excised portion of the gastric fundus through a gastrotomy. The hospital itself was huge. I visited famous parts of the hospital, including the famous Chagall stained glass windows, as well as Albert Einstein’s Nobel Prize, both of which are housed in the Medical Center.
32I toured the construction of new operating rooms in the hospital. The current operating rooms are quite old, having been built in the 1970’s. Due to government mandate, certain areas of the hospital (including the operating rooms) must be resistant to chemical, biological and nuclear war. As a result, the new operating rooms are being constructed four stories below the basement, in reinforced concrete bunkers with thick concrete walls. Although the result is a very stark, quite, and “industrial” environment, the project crew in charge of constructing these new ORs seemed very aware of the need to keep them personal and comforting, including a lot of outside images in the artwork, for example.

Overview/synthesis

Throughout my travels, which took me to a number of continents, countries, cultures and health systems, I identified a few themes which I thought were of note, and warranted further reflection.

The role of the professional colleges

During my training and professional career, I had developed the misunderstanding that the entities that license, regulate and educate surgeons were more or less similar. In Ontario, Canada, for example, the College of Physicians and Surgeons of Ontario (CPSO) serves as a self-regulating body for the practice of medicine that protects and serves the public interest, by serving certificates of registration to physicians and investigating public complaints. The Royal College of Physicians and Surgeons of Canada (RCPSC) performs a variety of activities to strengthen the practice of specialty medicine and surgery, such as accreditation of residency programs, verification of requirements for certification of specialist physicians, conducts certification examinations, maintains certification of specialist physicians through continuing medical education programs, and a variety of other policy, advocacy, and educational activities. I had assumed that the regulation and support of surgical practice throughout the world had a similar structure; in the United States, for example, the American College of Surgeons and American Board of Surgery together have a similar mandate to the RCPSC, and the state licensing authorities provide functions similar to our CPSO.
What I discovered, though, is a large variation and richness in the different approaches for certification, regulation, discipline and education of surgeons and specialist physicians. Some Colleges have a long, rich history and are very innovative in serving the needs of practising surgeons and trainees, such as the Royal College of Surgeons of Edinburgh. Some are expansive, and serve as the only major entity with responsibility for governance and education of surgeons, such as the Royal Australasian College of Surgeons. Some of these Colleges found themselves in conflict between serving both the needs of trainees and practising surgeons. In each case, the development of these regulatory, investigative and educational entities served the local needs of the surgeons and the public, and appeared to fit within the culture of practice of the geographic region where it developed.

Attributes of successful surgical leaders

In my travels, I had the opportunity to interact with many contemporary luminaries in academic surgery. I was continually surprised at how welcoming they were to me as hosts, how much time they took to make my visit so enjoyable, and how much personal interest they took in me. I did note a few attributes of effective surgical leaders. First, none seemed to develop their authority through power, intimidation, or autocracy. Rather, they all were interested people, good listeners and communicators, ran meetings efficiently but always asking people—by name—for their input. They appeared to earn the loyalty and support of others by genuine interest in the common cause and by a personal commitment to development and excellence of the larger interest rather than any personal gain. Second, they all had original and innovative visions for development in surgery; ideas that were “disruptive” more than “incremental”. Just a few examples would include Professor the Lord Ara Darzi and technological innovation in minimally invasive surgery; Professor O. James Garden’s innovations in trainee education; and Professor Guy Maddern’s innovations in technology assessment and clinical audit. A compelling original idea, and an energetic and passionate vision to carry it out, appears to be a pre-requisite for creating something spectacular. Third, they all found creative means to support their activities. Recognizing the limitations of typical sources of material support (hospitals, universities, funding agencies), these leaders found opportunities in unexpected places: governments, foundations, philanthropic donors, colleges, and subscription services, to name a few. Finally, they all served as role models, and had strong credibility as clinical surgeons. The most important constituency to win in establishing a position of leadership is that of your peer surgeons, and that will come only to those who are viewed as clinical leaders in our work as surgeons.

Succession planning

A related concept to that described above regarding the attributes of successful people is the issue of long-term sustainability of their signature programs, and succession planning. Successful academic surgeons are very busy people, tend to be very hands-on, and are frequently the singular creative spirit and driving force behind their programs. In many instances, the academic programs were hard to summarize succinctly; they were more a physical realization of a surgeon’s imagination rather than a conventional research unit. However, the very uniqueness, complexity, and category-defying nature of these units pose a major challenge to their long-term sustainability. In many instances, day-to-day management, and occasionally a strategic creative voice, was delegated to a program manager (often a protègè or PhD scientist). However, it was difficult for me to imagine many of these programs continuing in their established creativity and impact after the departure of the surgical leader. Tellingly, none of the programs I visited were “inherited” from somebody else. I asked some of the surgical leaders about this; many acknowledged that the issue of succession planning and long-term sustainability after their departure was not something they had an explicit plan for. I imagine that in many cases, programs will be broken up, with some of the components taken up by junior partners or scientific leads, while the remaining parts of the program many disappear. What became very clear to me was the importance of building effective layers of leadership within a program, and delegating important creative aspects to junior people where possible.

Conclusion

My experience as a James IV travelling fellow was the highlight of my professional career. I learned a lifetime of lessons about the world, about people, about programs, and about building a vibrant and creative future for academic surgery. I am grateful to the James IV Association of Surgeons for providing me with this opportunity. I will carry these insights and lessons with me for life.

2011 – Thomas L. Forbes

I was thrilled when I was notified that I had been honored as a James IV Traveller joining a group of individuals from my university including Drs Angus McLachlin, Dave Grant, John Duff, Vivian McAlister and Ken Harris. I’d like to personally thank my former chief, Ken Harris, for putting my name forward and advising me as I developed my travel plans. In the end I decided to split my travels into two periods, a two week visit to England and an almost 4 week visit to New Zealand and Australia. I was impressed by the hospitality of all my hosts and their willingness to have me visit their centers.
This proved an outstanding experience. I met fascinating individuals with which I have begun to collaborate with and will remain in touch with for the rest of my career. Some have even visited my center since my travels.
The following includes a brief description of my James IV travels:

London, England (May 2011)

I had decided to split my travels into two periods of time with my first visit being to the Imperial College in London, England where my host was Professor Lord Ara Darzi. Lord Darzi is a general surgeon who developed many of the innovative laparoscopic and less invasive technologies that our patients benefit from today. He was also at the forefront of simulation technology and its role in medical education and the development of simulation centers. More recently he has developed the Institute of Global Health Innovation (IGHI) within Imperial College and a team of health policy analysts and advisors that are involved in projects around the world. Lord Darzi’s expertise in health policy was recognized by Prime Minister Tony Blair’s government when he was appointed to the House of Lords and contributed to significant reforms in the British National Health Service, at the same time as continuing to practice as a surgeon and lead a busy and academically productive surgical department.
My visit to London and Imperial College passed quickly as I was warmly welcomed and shown many of this group’s impressive accomplishments. Lord Darzi was very generous with his and his team’s time. I had the opportunity to meet with the IGHI Health Policy Team and was given an overview of the IGHI and Center for Health Policy. Their various ongoing projects were fascinating and ranged from advising on cancer care in the Middle East to setting up a health care service in Russia. The Health Policy team (Michael Macdonnell, Peter Howitt and Dom King) were truly impressive and justifiably proud of their accomplishments to date. These meetings opened my eyes regarding some of the challenges, but also opportunities, for health care provision worldwide.
Furthering the role of simulation in surgical education is a major strength and interest of the Lord Darzi’s Imperial College group. I was exposed to various forms of these efforts including a Virtual Worlds demonstration and a tour of the VR lab, a display of a distributed simulation in the blow-up theatre, a demonstration of NIRS technology and eye tracking. Specific to my specialty of vascular surgery was a demonstration of the vascular robot and ORCAMP that was kindly led by Celia Riga.
During my visit to Imperial College I gave a research presentation describing some of our experience with practically relevant research regarding abdominal aortic aneurysms. This was well attended by the members of the IGHI, simulation teams as well as clinical personnel. The audience seemed to appreciate our efforts and struggles with health policy and funding issues back home, as well as the increasing utilization of simulation in Canadian surgical training.
I then spent time with the Vascular Surgery team at Imperial College led by Professor Nick Cheshire. Nick was very hospitable, as was Colin Bicknell who took time out of his schedule to make sure I didn’t get lost. I participated in vascular surgery rounds and case presentations and was impressed by the complexity of cases seen in this major referral center. The clinical highlight of the visit was observing a case performed by Dr Hazim Safi from Houston who had been brought in to operate on a young man from Greece with an aortic coarctation. It was an impressive OR that day, a Greek patient, American and British surgeons and a Canadian observer, an experience I won’t soon forget.

New Zealand (August 2011)

I spent the good part of a week traveling to several centers in New Zealand on both the north and south islands. Arrived in Auckland in the early morning hours after a long trans-Pacific flight and having enjoyed the outstanding service of Air New Zealand. A little hint to anyone who hasn’t traveled with this airline, this is one pre-flight safety video that you want to pay attention to. Apparently there are several, but this one centered on the Kiwi’s passion, the sport of rugby and with the World Cup of Rugby being hosted in New Zealand later in September and October, this video was especially enthusiastic. Auckland is the largest city in New Zealand and home to 1.4 million, or one third of the country’s entire population. I arrived during their winter and the temperatures ranged from 3 – 12oC. During my stay in Auckland I participated in a dinner symposium with physicians, nurses and trainees from the Auckland City Hospital, including Andrew Hill, vascular surgeon, and Andrew Holden, interventional radiologist, who via a team approach have developed significant expertise in endovascular aortic therapies. This collaborative approach certainly resonated with me as it’s similar to that employed at our institution. Professor Hill gave a talk describing his experience with endovascular repair of aneurysms with a new stent graft, and Professor Holden presented several cases with challenging anatomy that were confronted with. Their experience is impressive and somewhat different from that at my institution, especially there more aggressive early approach to type II endoleaks and preferential preoperative embolization of the inferior mesenteric artery prior to endovascular aneurysm repair. I then described our experience with endovascular repair of ruptured aneurysms which requires an entire team approach and readily available personnel, expertise, and infrastructure at all hours of the day and night. Although physicians in Australasia have embraced endovascular aortic therapy to at least the extent of their North American counterparts, my impression was that they have not done so with ruptured aneurysms, primarily because of the problems with availability of qualified personnel. There followed extensive discussion regarding these hurdles and strategies to rectify them. I was struck by the similarities between the clinical challenges vascular surgeons face in different geographic areas and the differences between the local logistics of our practices.
During my stay in Auckland I had a short period of time to tour this beautiful city. The hospitality was so great that my hosts arranged a snowfall, Auckland’s first in 70 years. A great view of the city and surrounding region can be seen from the Sky Tower, that overlooks Waitemata Harbor and the campus of the University of Auckland is a beautiful place for a walk, or run, and offers beautiful views of the city as well. After my short visit to Auckland, it was off to the nation’s capital, Wellington, in the southern part of the north island. The weather was cold and rainy but I did tour the city a little and visited the national museum Te Papa, which is the Maori expression for “where old treasures are kept”. I participated in a meeting with the Wellington area vascular surgeons and we had an extensive debate regarding the long term outcomes of open and endovascular aneurysm therapy. I gave a talk describing the challenges of funding new technology, such as endovascular stent grafts, in the Canadian healthcare system. This was well received and also prompted extensive discussion about healthcare economics in our respective countries. Dr. Thodur Vasudevan gave a talk describing his centre’s experience with advanced endovascular cases with thoracoabdominal aneurysms that was especially impressive. There appear to be more similarities, then differences, between these systems in Canada and New Zealand.
The New Zealand system is a government run system with insurance companies as private partners. Health Authorities (27 in all) are tasked with organizing healthcare delivery in their respective regions. The training programs for vascular surgery are common between New Zealand and Australia in that upon successful completion, surgeons can practice in either country. Many of the trainees do spend time in the United Kingdom or Australia during their period of training.
It was then off to the south island and visit with the Christchurch vascular surgeons. Christchurch and just received a major snowfall and is truly a beautiful city, but, as most will be aware, was the victim of a major earthquake recently. Many historic buildings and churches were destroyed irretrievably. I was struck by how arbitrary the damage seemed with upright buildings situated next to piles of rubble. The effects of the earthquake persist with 30,000 people having moved away from Christchurch and reconstruction efforts delayed by continuing aftershocks. I participated in a symposium with the Christchurch and area vascular surgeons, interventional radiologists and trainees and again discussed our experience with endovascular repair of ruptured aneurysms. The Christchurch experience with ruptured aneurysms appears similar to that of the Auckland group and our discussions basically centered around the challenges of implementing a ruptured aneurysm protocol at their hospitals.
Throughout my stay in New Zealand, I felt extremely welcome by these warm and generous people. I would definitely like to visit again, perhaps in the warmer summertime weather. It was now time to leave my new Kiwi friends and colleagues and cross the ditch (Tasman Sea) to the west island (Australia).

Australia (August 2011)

I arrived in Australia and quickly made my way to Adelaide in South Australia where my hosts were Professors Guy Maddern and Rob Fitridge. Professor Maddern is the R.P. Jepson Professor of Surgery at the University of Adelaide and Professor Fitridge is the Head of Vascular Surgery. I couldn’t have asked for better hosts as they were truly generous and hospitable. Upon arrival I was generously invited to the Fitridge household for dinner by Rob, and his wife Jen and their two sons.
My family subsequently joined me in Adelaide and our large group (my wife and I and our four kids) were made welcome and given the run of the Maddern beachhouse. This outstanding setting was a perfect introduction for my kids to this beautiful country. Professor Maddern and his family generously hosted my family and the Fitridges at their beautiful house for a welcoming dinner. Despite their jet lag, my family was invigorated and excited by this generosity and hospitality.
During my visit to Adelaide I visited the Queen Elizabeth Hospital and participated in research rounds at the affiliated Basil Hetzel Institute for Translational Research. This Institute is across the street from the hospital and I envied the close proximity as it optimizes collaboration between clinicians and researchers in truly translational research endeavours. It is a set up that is currently lacking at many Canadian institutions. I gave a talk describing practical research with abdominal aortic aneurysms, practical in the sense of health policy, health economics and healthcare delivery perspectives. Among other talks were one by a graduate student describing her work with skeletal muscle ischemia reperfusion. Our basic science laboratory has had extensive experience with this line of research so I was quite interested in this. Professor Fitridge gave a fascinating talk outlining their experience with risk stratification and predictive models with endovascular aortic surgery. I found this especially interesting as this has been a long time interest of mine. I learned a great deal and we discussed several possible opportunities for collaboration and information exchange.
During my visit to Adelaide I also participated in ward rounds at the Queen Elizabeth Hospital with Professor Fitridge and his multidisciplinary team that included physicians, trainees, nurses, social workers and podiatrists. I found the addition of podiatrists to be quite useful especially with those patients with diabetic foot infections, which often prove quite challenging to manage. I also participated in a multidisciplinary case conference with surgeons and radiologists where different approaches to several challenging cases were discussed.
A unique feature of my Adelaide visit was to draw on Professor Fitridge’s experience with international vascular surgery curriculum for trainees. This is a specific interest of his. Vascular surgery training in Canada has recently changed from a subspecialty of general surgery to a primary specialty, similar to that in Australia. Professor Fitridge is organizing a group to further international curriculum development and we will now participate in this worthwhile project.
After I quickly mastered driving on an unfamiliar side of the road, my family and I did set some time aside to explore Adelaide and the surrounding area. A visit to the Cleland Conservation Center, a short trip outside of Adelaide, gave us the opportunity to walk among the kangaroos, wallabies, koala bears and many other of the unique Australian animals. We also took the ferry across to Kangaroo Island where we spent a day and night exploring the island and saw penguins, sea lions, seals and more kangaroos. Its an area of the country where we were made welcome and where I would visit again anytime, both from the family and the professional aspects.
We then traveled to New South Wales where we spent time in Sydney, home of the world famous Sydney Opera House and Harbour Bridge. My kids and I took surfing lessons at Manley Beach where they were much more successful than I was, without a doubt. While my family explored Sydney’s well known zoo and aquarium I spent time at the Royal Prince Alfred (RPA) Hospital.
My hosts at the RPA were Professors James May and John Harris who met me for a welcoming tea at the Australia Club. They continued to be outstanding hosts during my stay that included lunch overlooking the rugby pitch on the University of Sydney campus. The RPA is a historic Australian hospital and also has played a major role in the development of endovascular aortic therapies, first under the leadership of Professor May, and then under Professor Geoff White and now under the leadership of Steve Dubenec. I was honoured to give a presentation to their group describing the progression of endovascular surgery in Canada and its effect on surgical training. During my visit, Professor May gave generously of his time and gave me an extensive tour of the hospital. I had the opportunity to participate in two sets of case base rounds, the first with Professor May and the vascular surgery trainees and the second with the entire vascular surgery group. During this second session I gave a talk entitled, “Revisiting a preferential endovascular approach to blunt traumatic injuries to the thoracic aorta.” This was well received, prompted much discussion, and also seemed to reflect the current practice and direction of the RPA group.
Following our Sydney visit it was time to spend some dedicated time with my family. We traveled to Cairns and eventually ended up near Port Douglas in northern Queensland. This was the perfect jumping off point for visits to the Great Barrier Reef and the Daintree Rainforest. These were once in a lifetime family opportunities that I was thrilled to share with my family.